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Abstract
Currently protons and carbon ions are the only heavy charged particles used
for radiotherapy. There is particular interest in the use of helium ions for
therapy, as they present physical dose and clinical advantages over carbon
ions and protons. In this thesis, a Fixed Field Alternating Gradient (FFAG)
approach has been developed for helium ion therapy, which has never been
explored before. Two non scaling FFAG accelerators are designed, acceler-
ating He2+ ions to 900 MeV, the necessary energy to reach 30cm depth in
tissue.
Initial steps have characterised the beam optics in order to achieve isochronous
stable equilibrium orbits over the design energy range described above,
whilst maintaining the working point with few resonance crossings. The
desired energy range of the machine is split across two stages, of which
both were successfully optimised to have a time of flight to within 1% of
each other. A common operating RF frequency has been identified, and the
RF parameters that are currently achievable were assessed and suitability
for this design investigated. Having successfully chosen realistic RF param-
eters, a beam has been accelerated and it has been demonstrated that there
is a sufficient dynamic aperture and extraction is possible.
The feasibility of a nsFFAG accelerator for the purposes of helium therapy
has been successfully investigated, and a helium ion beam was successfully
accelerated through simulation from 1 MeV to 900 MeV across two stages,
using fixed frequency acceleration. The design is compact, though splitting
the design into two machines has increased the footprint. However, the first
stage has the potential to be used as a standalone facility for research and
shallow tumours, and the accelerator could likely fit in a current radiother-
apy bunker. Further work will need in depth design studies to model the
magnetic field and RF cavity designs, to verify the design.
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In this thesis the design of a novel compact accelerator, a non-scaling (ns) Fixed
Field Alternating Gradient accelerator (FFAG), is developed for therapy using light
ion beams; with a particular focus on helium ions. By using an ion lighter than car-
bon, the size of the accelerator can be reduced, increasing the likelihood the machine
will fit in currently established hospitals.
In 2015 cancer was the cause of death for more than one in four people, and in
England and Wales only 50% of people diagnosed with cancer survive for ten years or
more [1]. Radiotherapy is the 2nd most effective method of treating cancer after surgery
in the UK with 40% of patients receiving radiotherapy as part of their treatment plan
[2]; however globally this is 50% [3] [4].
1.1 External beam radiotherapy: A history
Ionising radiation has been used medically for just over a century since its discovery,
beginning with Wilhelm Röntgen in 1885 where he used x-rays to image the hand of
his wife [5]. Just over a decade later Victor Despeignes irradiated a patient to treat
a stomach tumour [6], becoming the first recorded case of ionising radiation used to
treat cancer [7] [8]. Particle accelerators have played a part in radiotherapy since
Cockcroft and Walton’s 1932 high voltage generator [9], where less than a decade later
in 1937 they were used to generate mega electronvolt (MeV) X-rays to investigate the
biological effects of higher energy X-rays [10] [11]. Greater energies beyond 1 MeV were
surpassed with the help of particle accelerators again, by accelerating electrons using
linear accelerators or linacs. The first radiotherapy treatment facility was built in the
Hammersmith hospital, London, UK delivering 8 MV x-rays in 1953 [11] [12]. 65 years
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later, linacs have advanced with technology and are the work horses of radiotherapy
globally.
1.1.1 Proton therapy
Proton therapy is becoming an increasingly popular radiotherapy modality, offering
more conformality than conventional treatment. In 1946 Robert Wilson stated that
high energy protons could reach useful depths in tissue and be used therapeutically,
and the way protons interact with matter could be taken advantage of [13]. The
difference in the mechanisms that cause energy loss between protons and x-rays make
protons more suitable to irradiate tumours proximal to critical structures, as they can
be controlled to deliver a peak dose at a desired depth. The principles stated by Wilson
60 years ago are still true to this day and are discussed in detail in Chapter 3.
The Cockcroft Walton generator was designed to accelerate protons for nuclear
physics experiments. However, at the several hundred kVp generated the penetrative
distance of protons in tissue was negligible in comparison to x-rays and were overlooked
as a treatment modality. The development of particle accelerators, in particular the
cyclotron created by Earnest Lawrence [14], led to larger cyclotrons, and with them
protons in excess of 100 MeV being produced. It was at this point that Wilson
identified the potential protons have as a treatment modality. Less than a decade later,
the first patient was treated with external beam proton therapy at Lawrence Berkeley
National Laboratory (LBNL) in 1954 [15]; a year after the first medical linac was built.
Patients were continually treated in excess of 30 years at nuclear laboratories across
the world, before it was approved as a method to treat cancer in 1988 by U.S. Food
and Drug Administration (FDA) in the US, and dedicated proton therapy facilities
started to appear. The first medical proton therapy facility was again built in the UK,
at the Clatterbridge centre for ocular tumours [16]. In the last 30 years another 69
proton therapy facilities globally have become operational, and since the first patient
approximately 150,000 patients have received proton therapy up to the end of 2016
[17].
1.1.2 Proton therapy in the UK
The first medical proton therapy facility in the UK, was built at the Clatterbridge
Centre for ocular tumours [16]. Due to the size of the eye, only a small penetrative
depth is necessary. The facility provides a 60MeV proton beam, which reaches a depth
of up to 3.1mm in water. It has taken the UK nearly 30 years since Clatterbridge to
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construct a full energy proton beam facility, the first being a privately constructed in
2018 by Proton Partners International (PPI) in Newport, Wales [18].
As a treatment modality, full proton beam therapy was not available for patients
until April 2008, where the NHS introduced an overseas funded scheme for patients
that met specific clinical criteria. The scheme would send patients and families abroad
for up to 10 weeks to receive treatment in a facility abroad and has successfully treated
over 1000 patients [19] [20]. In 2015 the UK approved the construction of two NHS
proton therapy facilities, the Christie in Manchester, and University College London
Hospitals (UCLH). The Christie is hoping to treat their first patient this year, while
UCLH are planning the treatment of their first patient in 2020. Each centre hopes to
deliver treatment to 750 patients per year, greatly increasing the option of the treatment
modality for patients in the UK.
PPI are a private company also offering proton therapy and as mentioned delivered
the first full proton beam therapy in the UK. PPI have two more sites planned within
the UK, one in located in Borsmund, and the other located in the Thames Valley. It is
understood that these centres will be accepting NHS patients.
1.2 Ion therapy
The term ion therapy refers to ions heavier than protons used for external beam radio-
therapy, but at the time of writing is specific to carbon ions; as no other ions are used
clinically for the treatment of cancer [21]. The physical effects of protons identified
by Wilson in 1946 are mass dependent and can be amplified when heavier ions are
used. The use of heavier ions provides an even more localised dose and have a greater
biological effect.
The first use of ions as a treatment modality came in 1975 with the construction of
the BEVALAC at LBNL in 1975 [22]. Around 3000 patients were treated with different
ion species: carbon, neon, silicon, argon and helium between 1975 and 1993. The results
indicated the potential of carbon and neon beams, which led to the development of the
first dedicated carbon ion medical facility at the National Institute of Radiological
Sciences (NIRS) in Japan in 1984 [23]. The heavy ion medical accelerator (HIMAC)
treated its first patient in 1994. Since then, another 10 carbon ion medical facilities are
in operation, totalling 11 globally. Over 20000 patients have been treated with carbon
ions since the construction of HIMAC up to the end of 2016 [17].
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1.2.1 The limitations of ion beam therapy
The limitation in using particles for therapy lies with the accelerators necessary to
achieve the energies for therapeutic beams; the different types of accelerator will be
discussed in more detail in Chapter 3. As the mass of the particle species increases,
they require more energy to achieve the same penetrative depth in tissue. The difficulty
of delivering these energies can be interpreted by the number of patients treated since
the method has been available. Approximately 170,000 patients have been treated
globally with protons and carbon ions since up to the end of 2016, whereas in the UK
alone, 134,000 patients were treated with conventional radiotherapy in 2015-2016 [24].
Proton therapy accelerators are decreasing in size and the number of facilities be-
ing installed in current hospitals is increasing. UCLH demonstrate this by installing a
proton beam facility in central London. Typically, cyclotrons are used, and MEVION
offer a one room cyclotron solution with a gantry that can fit in a current radiotherapy
bunker, the size of which is approximately 50m2. Ion therapy accelerators however
require much larger facilities, typically a new site is needed as they are too large to fit
in current hospitals. All of the ion therapy accelerators globally are large synchrotrons
and the accelerator alone requires approximately 6.5 times the space of a current con-
ventional radiotherapy bunker. Ions lighter than carbon are easier to accelerate, the
reduced particle mass requires less force to bend the particle. This allows for a smaller
accelerator and hence reduced cost.
When using carbon ions therapeutically, a large number of low Z secondaries are
produced and travel beyond the range of primary ion. The secondary particles are
produced by fragmentation, the breakup of a primary ion via an inelastic nuclear in-
teraction with tissue. These secondary particles may travel beyond the range of the
primary ion and create a dose tail. This is undesirable for tumours situated proximal
to a radiosensitive structure, as it will be damaged by the dose tail. The number of
secondaries produced can be reduced by using a lower Z ion instead of carbon.
A potential solution to reduce the size of an ion therapy facility would be to use
a lighter ion species. A lighter ion species would also reduce the fragmentation dose
tail. Helium is the easiest ion to accelerate after protons, and is a compromise between
carbon and protons, yet still obtaining advantages of ion therapy.
This thesis represents a feasibility study of the acceleration of helium He2+ ions
using a nsFFAG accelerator. Ultimately size is cost, and using a nsFFAG accelerator
will potentially allow for smaller accelerator and an overall reduced footprint, and hence
a reduced cost. Ideally the accelerator will need to have a comparable footprint and
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cost to conventional radiotherapy suite and be able to fit comfortably inside a hospital.
The questions to be answered are whether it is possible to accelerate an isochronous
helium beam, are FFAGs a technically feasible option for therapy with helium and how
would their performance and cost compare with other possible options.
1.3 Thesis layout
Chapter 2 addresses the core principles of the interaction of radiation with matter,
detailing the advantages of charged particles over x-rays for the treatment of cancer.
The chapter then discusses some of the current shortfalls of ion therapy, and how he-
lium may be a potential solution for some of the issues. Chapter 3 concentrates on
the fundamentals of accelerator physics and the types of accelerators currently used to
accelerate particles for therapy. Fixed Field Alternating Gradient (FFAG) accelerators
are introduced and how they are suitable for accelerating ions for therapy. Chapter 4
begins looking at different design iterations for a helium ion accelerator, specifically fo-
cusing on the time of flight (ToF) and resonant instabilities of the accelerator to achieve
isochronous acceleration to relevant clinical depths. Chapter 5 builds on the designs
developed in Chapter 4, simulating the addition of RF cavities, and identifying the
stable acceleration orbit. Considerations are made to identify realistic RF parameters
using the Kilpatrick limit [25] and by assessing the RF in similar operating machines.
Chapter 6 then looks at accelerating a typical beam from similar machines through
the accelerator and extracting the beam when it has reached its design energy. To
assess the extraction of the beam the orbit separation is discussed, and the injection





Radiation in cancer therapy
Radiotherapy describes the use of controlled ionising radiation to purposely damage
unwanted cells in an attempt to kill them. In this chapter, the biological rationale for
radiotherapy will be discussed, and some terminology relating the physics to the biology
will be addressed. The interaction of radiation types with matter will be discussed, to
explain the science behind the choice of different radiation types for the treatment of
cancer. The limitations will be explored, and the current status of proton and ion
beam therapy will be discussed in detail, before highlighting why helium may be the
compromise necessary to increase the availability of ion therapy.
2.1 Biological rationale for radiotherapy
Many radiation types interact with matter and deposit energy via ionisation. Ionisation
within a cell can trigger chemical reactions, which in turn damage critical structures
within the cell, namely the DNA.
DNA consists of two polynucleotide strands joined in a helical structure by a co-
valent bond. If it becomes damaged, breaks appear in either or both strands of the
DNA, identified as single strand or double strand breaks. Eventually when the cell
replicates, it will be unable to do so as the DNA of a cell is damaged. The cell will
try to repair the DNA through different repair mechanisms, which may be successful,
partially successful or fail. A successful repair will present the DNA as if there was no
interaction with radiation, a partial repair introduces a mutation that does not impair
cell function, and failure to repair results in cell death. Both single and double strand
breaks can be repaired, but it is more difficult to repair a double strand break and the
likely result from an incorrect double strand break repair is cell death.
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Radiation can damage the DNA structure of a cell by either direct or indirect
damage. Direct damage is when the radiation type directly interacts with the DNA in
the cell. Indirect ionisation refers to the ionisation of water, which is the majority of
the structure of cells. Ionising water creates free radicals in the cells which eventually
damage the DNA and produce single strand breaks. As direct ionisation is more likely
to result in double strand breaks and hence cell death, it is the desired outcome of
radiotherapy.
To increase the chance of direct ionisation, a larger amount of ionisation is needed on
a cellular level, or by using more densely ionising radiation. The amount of ionisation
per unit distance for a specific radiation type is described by the LET; the linear Energy
Transfer.
2.1.1 Linear energy transfer (LET)
Linear energy transfer (LET) is equivalent to the stopping power (dE/dx) in physics and
quantifies the amount of energy deposition per unit distance. At therapeutic energies,
deposition for radiation comes in the form of ionisation, so densely ionising radiation
has an increased LET. LET can be used as a tool to create treatment plans, but it is
complex due to the variation of LET as a function of energy [26].
A detailed discussion of LET is beyond the scope of this thesis, but it is important
to note that the evidence suggests a strong correlation between cell death and high
LET. [27] [28].
2.1.2 Relative biological effectiveness (RBE)
The term relative biological effectiveness (RBE) is used to relate the effects of one
ionising radiation type to another. For a given amount of biological damage to a
particular type of tissue, the RBE is the ratio of the absorbed dose, DT for one radiation





RBE is set to 1 for photons and 1.1 for protons for therapeutic energies. The LET
for particles is dependent on its energy and as a result the RBE for protons arguably
changes with respect to its LET and how densely ionising it is. However, it should be
noted the literature agrees there is a positive correlation between RBE and LET i.e.
particles with an increased ionisation density deliver more biological damage compared
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to x-rays for the same absorbed dose. Like LET a detailed discussion of RBE is beyond
the scope of this thesis [29].
2.1.3 Absorbed dose, equivalent dose and effective dose
Radiation dose describes the energy deposited from radiation into tissue. Equation 2.2
describes the absorbed dose; the energy deposition per unit volume. The SI unit for






Absorbed dose, however, does not account for the radiation type causing the dose,
which may result in different effects quantified by weighting or quality factors. The
quality factors are based on experimental RBE values for cancer induction at low doses
and rates [31] [32]. To quantify the biological difference in dose by different radiation
types the term equivalent dose is used. Equivalent dose it calculated by multiplying
the absorbed dose by the radiation weighting factor for the radiation type, as shown in
Equation 2.3.
HT = DT ×WR (2.3)
Where HT is the Equivalent dose which is measured in Sieverts (Sv), DT is the
absorbed dose and WR is the radiation weighting factor.
Certain organs or areas of the body are more sensitive to radiation than others, and
different quantities of equivalent dose translate to a different biological effect. The Ef-
fective dose, ET , is calculated by multiplying the equivalent dose by the tissue weighting
factor WT as demonstrated by Equation 2.4. Effective dose is also measured in Sieverts.
ET = WT ×HT (2.4)
The damage from radiation to healthy cells is split down two pathways, deterministic
and stochastic. Deterministic effects are seen when a certain amount of radiation has
been absorbed by tissue and there is sufficient cell death to impair function. Examples
of deterministic effects would be epilation or radiation sickness. Stochastic effects
are probabilistic effects that increase in probability linearly with the amount of dose
absorbed. Deterministic effects in therapy are normally acute. Stochastic effects relate
to the chance of secondary malignancies via the generation of mutations in DNA repair.
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When constructing treatment plans both types of damage are considered to spare as
much damage to healthy tissue as possible [31].
2.2 Conventional radiotherapy
When radiation traverses a material, it will lose energy on its path, which mostly comes
from ionisation. The ionisation mechanism is the process of gaining or losing an electron
from an atom, creating an ion.
Ionisation can occur directly when a charged particle passes through a medium.
It is also possible to ionise indirectly where ionisation occurs from the production of
secondary charged particles. Indirect ionisation is generally associated with neutral
particles, like neutrons or photons, as they are unable to ionise directly. Particles that
are indirectly ionising may not interact with the medium and its presence would never
be known, whereas for a charged particle this is not the case. The most common type
of radiotherapy, conventional radiotherapy, uses x-rays to damage cells. Conventional
radiotherapy has been successfully used for many years, but the desire to look at other
directly ionising radiation types for radiotherapy is rapidly increasing; especially for
external beam treatments. The rationaleor looking at other radiation types can be
explained by looking at the way photons interact with matter.
2.2.1 Photon interactions with matter
Photons (x-rays) ionise indirectly because they are chargeless, massless packets of en-
ergy and produce secondary charged particles to ionise a material. The intensity of a
beam of photons attenuates as they travel through a medium and this gradual energy
loss is through three different energy dependent interactions; the photoelectric effect,
Compton scattering and pair production. Depending on the energy of the incident
photon and the Z value of the material traversed, one type of interaction will dominate
as depicted in Figure 2.1.
2.2.1.1 The photoelectric effect
At low energy the Photoelectric effect dominates, and it describes the liberation of
electrons from a material, called photoelectrons. In this process a photon interacts with
an electron in the medium and its energy is wholly absorbed by the electron. Providing
the energy of the photon is at least equal to the binding energy of the electron, a photo-
electron will be emitted. If the absorbed photon has an energy greater than that of the
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Figure 2.1: A depiction of the dominant photon interaction for a given photon energy for
varying absorber atomic number [30]
binding energy, the remaining energy will become kinetic energy for the electron. If the
energy of the photon is less than the binding energy of the electron the energy will still
be absorbed and the electron will likely move to an excited state and return to a lower
state, releasing the energy via spontaneous emission. The photoelectric effect requires
a threshold Energy of light to create photoelectrons and is independent of the intensity
of the light source below the threshold Energy. For all intents and purposes this is true,
because the energy that is absorbed is held for a very short period. However, if the
intensity was high enough so that two or more photons could be absorbed by the same
electron before spontaneous emission or kinetic energy loss occurred, photo emission
can be observed.
2.2.1.2 Compton Scattering
As the energy increases Compton scattering becomes the dominating process between
photons and electrons. Like the photoelectric effect the photon imparts energy to the
electron, but instead of the photon being absorbed, it gets scattered by an angle θ. The
electron is always ejected in this interaction, at a different angle to the photon, ensuring
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energy and momentum is conserved. The angle in which the photon is scattered relates








Where Eγ is the energy of the incident photon, Eγ′ is the Energy of the scattered
photon, me is the electron rest mass, c is the speed of light and θ is the scattering
angle.
2.2.1.3 Pair production
As the energy of the incident photon increases beyond 1.02 MeV the pair production
process begins to dominate. The pair production process occurs when the incident
photon converts to an electron and positron pair; hence the photon energy must be
greater than or equal to the rest mass of both particles. Energy and momentum must be
conserved in this process, so the interaction needs to happen near a nucleus to conserve
momentum as it is forbidden in free space. The created positron will eventually lose
all its kinetic energy via moderation and annihilate with an electron. Annihilation
is the name given to collision between a particle and its anti-particle to produce new
particles; momentum, energy and charge must be conserved. In this case the electron
and positron will annihilate at rest, and the resulting particles will be two back to back
photons each with the energy equivalent to 511 keV to conserve energy and momentum.
The electrons produced from the above processes further ionise the material, and de-
posit energy. The Energy deposition of electrons is accountable for all of the ionisation
from photons and will be discussed later in this chapter in Section 2.3.4.
The three energy loss processes create the depth dose profile depicted in Figure
2.2. Typically, up to 10 MeV photons are used currently in radiotherapy. Photons do
not stop unless all of their energy has been lost as described in the processes above.
Depending on the depth of the tumour, the dose received from photons will change,
and there will always be unwanted dose delivered to healthy tissue.
2.2.2 Current status of radiotherapy
The irradiation of healthy tissue is generally the limiting factor of a treatment plan, and
the balance between delivered tumour dose and healthy tissue complications caused by
dose are considered [34] [35]. This is undesirable, and can cause side effects depending
on where the radiation is being delivered for treatment [34] [36]. The advances of
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Figure 2.2: The percentage depth dose curve for 6 MeV photons [33]
radiotherapy have reduced the irradiation of healthy tissue by introducing multileaf
collimators or conformal radiotherapy, image guided radiotherapy (IGRT) [37], and
intensity modulated radiotherapy (IMRT). IMRT utilities multiple beams of different
profiles and intensities to reduce the dose to healthy tissue and deliver a more conformal
dose to the tumour [38]. Current IMRT modulates the beam as the linac rotates around
the patient, known as volumetric arc therapy (VMAT) or RapidArcr. This increases
conformality as many more angles are utilised and reduces treatment time as the linac
is not stopping and starting to set up for different angles. However due to the dose
profile shown in 2.2, further changes are required increase conformality.
2.3 Proton therapy
Figure 2.3 compares the relative dose as a function of depth for protons (red) and
photons (purple) for a single beam. A protons range is dictated by its energy and can
be controlled to stop at a given point, known as the Bragg peak. The Bragg peak
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Figure 2.3: A depiction of protons, photons and electrons relative dose deposition in
terms of entrance dose as a function of depth in tissue [39]
is also the highest region of dose deposition for protons, contrary to photons where
peak radiation dose for photons is delivered near the surface of the medium. The fact
that protons stop as opposed to continually ionising a material is a huge advantage over
photons. This is especially crucial when irradiating a tumour proximal to radiosensitive
organs, identified as organs at risk (OAR), where a photon beam would continue to
ionise the material until sufficiently attenuated. The blue line on Figure 2.3 shows
the depth dose curve for the spread out Bragg peak (SOBP). By using a single proton
beam, the resultant peak is narrow and may partially irradiate the tumour. To ensure
full tumour coverage, it is possible to use several energy modulated proton beams to
create a flat wide dose plateau, identified as the SOBP. Protons are directly ionising,
and have a higher LET compared to photons, hence increased chance of causing cell
death. The depth dose curve for protons can be explained by the way charged particles
interact with matter.
2.3.1 Charged particle interactions with matter
Charged particles interact with matter elastically and inelastically, where in both cases
the momentum is always conserved. Elastic collisions can occur with either the nucleus
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or other electrons within the material, conserving the total kinetic energy. Inelastic
collisions occur when kinetic energy is not conserved as the particles lose kinetic energy.
Charged particles lose kinetic energy from two main processes; collisional and radiative
processes. These are energy dependent processes and relative to the incident particles
mass. Radiative energy loss requires particles to be highly relativistic, which is not
within the scope for heavy charged particles used for therapy. Electrons specifically
may exhibit radiative losses depending on their energy, which will be discussed later in
this chapter.
Collisional and radiative interactions will happen until the incident particle has lost
all its kinetic energy to the medium. This process is generally simplified to represent the
amount of energy lost per unit distance for a given medium, known as stopping power,
which is the sum of the energy lost from collisional and radiative processes combined.
2.3.2 Charged particle collisional losses
The incident charged particle has a Coulomb field, and when it traverses a material
it affects the surrounding charged particles by repulsion or attraction. The generated
Coulomb forces between the incident and surrounding particles transfer kinetic energy,
which scatters the particle inelastically. Inelastic scattering with the orbital electrons,
known as electronic collisions, may transfer enough energy to excite or ionise the atom.
Like the outcome of the photoelectric effect, the energy received by orbital electrons
allow them to rise to an excited state, and then potentially de-excite releasing photons.
If an outer electron receives enough energy it may be ejected from the atom, creating
an ion. The process of energy loss through electronic collisions is well understood and



















where x is the distance traveled by the particle, K= 4πNAr
2
emec
2, NA is Avogadro’s
number, re is the electron radius, A is the atomic mass of the absorber in gmol
−1, z is
the charge of the incident particle, Z is the Atomic number of the absorber, β = v/c,
the ratio of the incident particle to the speed of light, γ is the Lorentz factor, I is the
mean excitation energy of the medium, δ(βγ)/2 is the density correction and Tmax is
the maximum kinetic energy that can be lost in a head on collision with a particle, as
detailed in Equation 2.7.
The Bethe Bloch Equation is only suitable for ions with a mass much greater than
electrons. This is because electronic losses are more significant for electrons. Electronic
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collisions are the main source of energy loss for charged particles traversing a medium in
the range of therapy. The energy lost by a proton is stochastic, but the maximum energy
it can lose would be in a head on collision with an electron. The energy dependent
maximum kinetic energy loss for an electronic collision is written in Equation 2.7. It
can be noted that for a given material the rate of energy loss essentially is a function of










where m is the mass of the incident particle, everything else is as described.
Because collisions are random, maximum energy loss is not guaranteed, and the
range of the particle may vary due to the number of collisions it encounters. This is
known as range straggling, and needs to be accounted for in proton therapy, especially
through different tissue types and thicknesses. The range of a ion is identified at the
depth where 50% of all ions in the pulse have stopped [26].
2.3.2.1 Nuclear interactions
There is also the possibility that the incident charged particle will undergo nuclear
reactions with nuclei; an irreversible non elastic interaction. This gives rise to unwanted
secondary particles being produced that have the potential to travel beyond the Bragg
peak. The produced unwanted secondaries will contribute to the overall dose and effect
the RBE [40]. A summary of nuclear reaction data relevant to proton therapy can be
found in ICRU report no.63 [41].
2.3.3 Multi-Coulomb scattering
As discussed, elastic scattering occurs when the incident particle is scattered by the
electrons or nuclei present in the traversing material, conserving kinetic energy. In the
case of particle therapy, the traveling medium will be large, and the likelihood is many
scattering incidences will occur. The total scattering angle can be approximated to









[1 + 0.038\ln(x/X0)] (2.8)
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Figure 2.4: Taken from [42]. Quantities used to describe multiple Coulomb scattering.




the projection of the angle on a plane, βc is the velocity m/s, p is
the momentum in MeV/c, the charge of the incident particle is z, x is the thickness of
the material and X0 is the radiation length measured in g/cm
2. The radiation length is
characteristic of a material and describes the mean free path length for a radiation type
when its energy has been reduced by 1/e. The radiation length for a given material







where Z is the atomic number of the medium and A is the atomic mass of the
medium.
2.3.4 Electron interactions with matter
It has been identified that electrons are the cause of ionisation for photons and are
produced from heavier charged particle ionisation, so they have an important role in
radiotherapy.
Electron lose energy through collisional losses with orbital electrons like heavier
charged particles which have the same effect; causing excitation and deexcitation within
the atom or ejecting an electron directly creating ions.
Electrons are light in comparison to protons, hence they interact differently with
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matter as they will typically interact with other electrons. By substituting the mass of
the electron into Equation 2.7 it can be seen that an electron may lose all of its energy
in an electronic collision. This also translates into large scattering angles for electrons
when considered in Equation 2.8.
Radiative losses also occur for electrons when at relativistic energies, known as
Bremsstrahlung radiation. Bremsstrahlung radiation or breaking radiation is the emis-
sion of a photon to conserve energy, when an electron is deflected and slowed down by
a positively charged nucleus. The produced photons will then undergo the interactions
discussed in 2.2.1 to deposit energy in the material.
2.3.5 Current status of proton therapy
The concept of using protons therapeutically is more than 70 years old [13], the first
specific clinical implementation came 30 years ago, where before this accelerators de-
signed for the purpose of nuclear experiments were used to treat with protons. Although
proton therapy physically demonstrates advantages in conformality and the sparing of
healthy tissue [35], the delivery of proton therapy is more difficult; facilities are limited
because of their cost, size and lack of medical validation.
A medical linear accelerator (linac) is used to generate the x-rays used for conven-
tional radiotherapy. To generate the x-rays, electrons are thermionically emitted and
accelerated and focused on to a tungsten target. The energy of photons needed for
treatment is typically between 5 and 10 MeV, and hence represent the typical voltages
required to accelerate the electrons to the x-rays needed. Electrons are also ˜1⁄1800 the
mass of a proton, making the magnet field required to bend the electrons much weaker
in comparison to protons. For Protons to reach 30cm depth in tissue, 225 MeV is
needed, requiring bigger accelerators. Protons are heavier than electrons, and hence
have a larger beam rigidity, which is a quantity that describes the difficulty in bending
the beam at a given moment. A larger beam rigidity would require larger bending
fields, a larger bending radius or a combination of both field and radius. The beam
rigidity and total energy required to reach 30cm depth in water are highlighted in Fig-
ure 2.5 for all fully stripped ions up to carbon. Each colour in Figure 2.5 refers to a
different ion, and for a given particle energy the magnet strength in Tesla per metre
needed to bend the beam 90 degrees is plotted. For heavier ions it can be seen that
high magnet strengths are needed to bend the beam, so to counteract this the bending
radius is increased. Increasing the magnet length allows for weaker magnets, but at
the compromise of space.
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Figure 2.5: The bending radius necessary to bend the beam against kinetic energy for
fully stripped ions up to carbon. The energy necessary to reach 30cm depth in water was
calculated using SRIM [43]
Because of the much larger energies and magnets required, larger facilities are re-
quired, which has been a limiting factor in installing proton therapy in current medical
facilities. Typically, it requires new infrastructure which is costly. Where implemented,
circular accelerators are typically used to accelerate the particles. This is because us-
ing a linac would require a much larger facility. With the advancement in accelerator
technology, single room solutions are now available for proton therapy, improving the
accessibility of the technique.
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2.3.5.1 Current proton therapy solutions
The cyclotron is the most common accelerator used for proton therapy and can be
bought off the shelf. Cyclotrons are reliable machines that use large fixed field magnets
to create high current continuous beams and can be operated simply.
The recent trend has been to reduce the size of proton facilities, for example, Varian
offer a single room solution with a 360◦ gantry treatment room that will fit in a tennis
court [44]. With a current conventional facility, the size of 50m2, the Varian machine
is 4 times as large [45] [46]. MEVION however offer a single room solution that fits
into an existing vault using a superconducting mounted synchrocylotron on the gantry;
note the gantry can only rotate 190◦ around the patient [47].
Synchrotrons are also used for proton therapy but are less common. Synchrotrons
are pulsed beam accelerators where the orbit of the accelerator remains constant. Ac-
celeration occurs by varying the magnetic field and RF frequency with time to keep
the particles on orbit. Unlike cyclotrons, synchrotrons allow for variable energy ex-
traction, and can reach higher energies. A consequence to this is that acceleration is
not rapid, and changing energy takes time. They are generally larger than cyclotrons,
as they require pre-acceleration. Hitachi sell an off the shelf synchrotron for proton
beam therapy, which has a diameter of roughly 7m. This is comparable to the medical
cyclotrons; however this does not include pre injection.
Further medical validation needs to be demonstrated by clinical work and studies.
Aside from the many discussions about the RBE and LET of particle therapy [48] [49],
there are an insignificant number of cases of proton therapy relative to conventional ra-
diotherapy. To put this into context, by the end of 2016 approximately 150,000 patients
have been treated with protons [17]. In 2015-2016 in the UK alone 134,000 patients
were treated with radiotherapy [24]. In the 30 years since they were first used in hospi-
tals, there are now 70 operational proton facilities, which are exponentially growing in
number. The increased number in facilities now allows the necessary randomised trials
to justify clinical treatment selection and provide quality clinical based evidence [50]
[51] [52].
2.4 Ion therapy
Having discussed the benefits of protons over conventional radiotherapy, it is becoming
increasingly popular as a solution to achieve more conformal dose. The development
of using charged particles like protons, has naturally led to the development of using
34
2.4 Ion therapy
heavier ions for therapeutic use. Currently ion therapy solely relates to carbon ions,
which is the only ion being used therapeutically for radiotherapy. The physical benefits
achieved by protons are amplified as the mass of the primary ion increases. Comparing
carbon ions to protons the rms scattering angle, the standard deviation of the lateral
spread and longitudinal straggling are reduced by roughly by 75%; delivering a sharper
narrower Bragg peak [53] [54]. Carbon ions have a high LET, and an RBE two to
3 times that of photons [23], making them significantly more effective at killing cells
compared to photons and protons. Carbon ions have also proven beneficial to tumours
that have shown resistance to low LET radiation [29].
2.4.1 Carbon ion facilities
There are currently 11 ion therapy centres worldwide, 7 centres are in Asia while the
rest are in Europe. Compared to the number of operational proton therapy sites, there
are 6 proton therapy sites for every carbon ion therapy facility. [21]. In addition to
this, there are 5 carbon ion treatment facilities under construction [55]. Irrespective of
the biological rationale, the infrastructure necessary to build a carbon facility restrict
its location typically to new build hospitals, which can be indicated by the ratio of
carbon to proton facilities. All of these carbon facilities are dedicated synchrtrons and
are capable of accelerating all ions up to carbon with the same accelerator. There are
currently no off the shelf commercial solutions available for carbon ion therapy, however
Toshiba are prepared to offer a custom turnkey solution [56].
Out of the European centres, two facilities are in Germany, Heidelberger Ionenstrahl-
Therapiezentrum (HIT) in Heidelberg and Marburger Ionenstrahl-Therapiezentrum
(MIT) in Marburg, provide carbon ions up to 430 MeV/u with an approximate circum-
ference of 65m [57] [58]. The 3rd facility, Centro Nazionale di Adroterapia Oncologica
(CNAO) in Italy, accelerates carbon ions to 400 MeV/u with an approximate circum-
ference of 78m [59] . The final facility in Europe is MedAustron in Austria is based
on the CNAO model [60]. A gantry for ion therapy will require a footprint similar
to that of the accelerator. There are only two gantries present in the world for ion
therapy; a normal conducting gantry at the Heidelberg facility and a superconducting
gantry at HIMAC (Heavy Ion Medical Accelerator in Chiba), one of the facilities in
Japan. The Heidelberg gantry is depicted in Figure 2.6, it uses normal conducting
magnets and is approximately 600 tonnes, 25m in length and 13m in diameter [61].
The HIMAC gantry uses some superconducting magnets and is 300 tonnes, 13m long
and has a diameter of 11m [62]. The benefits of a having a gantry for treatment are
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obvious, however for ion therapy the footprint is as large as the accelerator significantly
increasing the financial and infrastructure cost. For the facilities that do not have a
gantry, static beam lines are successfully used at different angles. This is sufficient,
however this is at the expense of treatment time due to patient positioning
Figure 2.6: The Heidelberg Ion-beam Therapy Center rotating gantry [63]
2.4.1.1 Fragmentation
When a particle collides with tissue it may undergo an inelastic nuclear interaction. For
heavier ions this interaction may result in the ion breaking up into smaller daughter
fragments in a process known as fragmentation. The smaller fragments are lower z
secondaries relative to the incident particle and are produced with a similar velocity to
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that of the primary. The daughter fragments contribute to the total energy deposition
along the path of the primary, and because of their reduced mass have an increased
range, and will have an increased scattering angle. The target nucleus may itself also
break up, but this will be at a low energy and will not travel with the other secondary
particles. As discussed above, when the particle slows down, the ionisation density
increases due to the number of collisions. For heavier ions this increases the number
of nuclear interactions and hence the production of low z secondaries. The produced
secondaries in the Bragg peak then have the potential to travel beyond the Bragg peak
and create a dose tail. The dose tail is an unwanted side effect of heavier ion therapy,
and is counter intuitive to the initial concept of charged particle therapy being more
conformal and avoiding dose deposition proximal to the desired location; where radio
sensitive structures may be located. The amount of fragmentation from an ion increases
with mass, as depicted in Figure 2.7 [64] [52] [65]
Figure 2.7: A depiction of the relative dose as a function of depth for different ions. As
the mass if the ion increases, the fragmentation dose tail increases distally to the tumour
[64]
2.4.2 Alternative ions
The advantages of carbon ion therapy over proton therapy are evident, however the
produced dose tail is undesirable, and size and cost of the facility restricts the imple-
mentation of carbon ion therapy in currently established facilities and hospitals [54]. If
the HIT synchrotron is taken as an example, a 65m circumference translates to 336m2
just for the accelerator, which is roughly 6.5 current radiotherapy bunkers worth of
space. A compromise to increase the availability of ion therapy could be to use an
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ion lighter than carbon yet heavier than protons. Such light ions consist of helium,
lithium, beryllium and boron. The size of the facility can be reduced by using light
ions for therapy, as reducing the mass reduces the beam rigidity (Figure 2.5) and allows
for a smaller accelerator and hence reduced cost. Despite the benefits of carbon ion
therapy over proton therapy the cost and size of proton facilities are more reasonable,
demonstrated by recent installations in established hospitals
2.5 Helium ion therapy
Helium ions have been used as a therapeutic tool in the past. LBNL treated more
than 2000 patients with helium ions between 1977 and 1992 [66] [67]. Patients were
treated with an array of different dose schemes making it difficult to compare results
and analyse further [68], yet the work completed showed clinical benefits [69]. There
is a rising clinical interest in reviving the use of helium ion for therapy and a revival is
not unrealistic. Currently, the only facilities that can accelerate helium ions to relevant
therapeutic depths are carbon facilities, and research is currently ongoing to use helium
ions as a treatment modality in addition to carbon ions [70] [71].
Helium is the easiest light ion to accelerate after protons, and in terms of rigidity
is a compromise between carbon and protons. Having a mass four times greater than
that of protons, the rms scattering angle, the standard deviation of the lateral spread
and longitudinal straggling are roughly halved [53]. This is comparatively worse than
carbon, however the dose tail generated by low z secondaries is considerably less. Having
both physical advantages over carbon and protons, helium has the potential to be the
compromise to allow ion therapy to become more available.
2.6 Chapter summary
In this chapter the effect ionising radiation has on tissue was examined. The way differ-
ent radiation types interact with matter has been discussed, explaining the evolutionary
physical rationale for using charged particles for radiotherapy to improve conformity
from conventional radiotherapy. The increased mass of carbon ions used for ion therapy
delivers a more conformal dose, but the cost and size of the facility limit the availability.
Different potential ions that could be used instead of carbon were suggested, based on
their potential clinical benefit and reduced size and cost. Helium ions were highlighted
as the ion with the most potential to be used therapeutically. Research has started in





In this chapter the theory of particle acceleration will be discussed, covering the different
types of accelerators used medically. The medical requirements for a therapeutic beam
will be identified and how each accelerator type meets these demands.
3.1 Electrostatic acceleration
DC or electrostatic acceleration accelerates particles across a constant potential differ-
ence. The energy gained by a charged particle with charge q will gain kinetic energy
KE as shown in Equation 3.1
KE = q∆V (3.1)
where ∆V is the potential difference across the accelerating gap. Naturally from
Equation 3.1 the larger the potential difference, the greater the kinetic energy trans-
ferred to the particle. There are two well established electrostatic accelerator designs
that achieve high voltages used for accelerating particles; the Cockcroft Walton gener-
ator and the Van de Graff accelerator.
3.1.1 Cockcroft Walton generator
The Cockcroft Walton generator was designed by John Cockcroft and Ernest Walton in
1932, where they accelerated protons to 700 keV [9]. The accelerator design uses a low
AC voltage to produce a larger DC voltage, allowing the creation of a high potential
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difference to accelerate particles. The generation of the high voltage is created by a
voltage multiplier or, Greinacher multiplier, named after the inventor of the circuit
with the same name; Heinrich Greinacher [72]. The circuit consists of an arrangement
of diodes and capacitors, as depicted in Figure 3.1a. As the current flows through
the circuit, the first diode allows current to pass charging the first capacitor, whilst
the second capacitor is not charged because the second diode does not allow current to
pass and complete the circuit. Once the polarity switches on the voltage, the current
flows in the opposite direction, the first capacitor cannot now be charged as diode one
prevents the flow of current, charging capacitor 2 instead, with the additional charge of
capacitor 1; twice that of the original AC voltage. Combining many circuits allows the
voltage to be continually doubled up to a peak voltage in air before breakdown begins
to occur [73].
(a) A depiction of the standard voltage multiplier
diagram
(b) John Cockcroft and Ernest Walton working on
their self titled generator [74]
Figure 3.1: The Cockcroft Walton generator
3.1.2 Van de Graaff accelerator
A Van de Graaff accelerator or generator utilities a dielectric material on a belt on a
pulley to create a high voltage potential. The generator uses the triboelectric force to
purposely charge the rollers, turning the belt, generating electric fields. The generated
electric field ionises the air and charges the spherical surface at the top of the generator.
Invented by the physicist of the same name in 1933 [75], a Van de Graaff generator is
depicted in Figure 3.2a.
A motor controls the rollers at the top and bottom of the dielectric belt, causing
the belt to turn continuously. At the bottom and top of the belt there are two metallic
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(a) Schematic of Van de Graaff generator [76]
(b) The Daresbury NSF tower [77]
Figure 3.2: The Van de Graaff Generator
combs positioned very close to the belt, where the top comb is connected to a large
metallic sphere surrounding the structure. The motion of the belt against the lower
roller stimulates the tribolelectric force generating a positive charge on the belt, and a
negative charge on the roller. The negative charge on the roller then repels the electrons
present in the lower comb, making the comb positively charged, and generating an
electric field between them. Air molecules interact with the electric field, electrons
get attracted to the positive comb, leaving positive ions behind which get attracted to
the negative roller. The air ions do not reach the roller, as the dielectric material is
in the way, and the charges get carried by the belt. Once they reach the top of the
generator, the positively charged belt attracts electrons from the roller, making the top
roller positively charged. This in turn creates an electric field between itself and the
comb like the bottom roller, however it is the positive charge that gets repelled and
pushed out onto the connected outer spherical structure. The electric field generated as
below interacts with the air, and the positive ions continually charge the outer dome.
The limitation of the generator is determined by when corona breakdown occurs at the
sphere surface.
3.1.3 Tandem accelerator
Tandem acceleration utilised the charge of the particles accelerated in combination
with the Van de Graff generator. By changing the charge on the accelerated particle,
the repulsion and attraction of the charge can be taken advantage of to accelerate
the particle twice. The alternation of charge is usually undertaken by passing the
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charged particles typically through argon or nitrogen gas or a carbon foil. Typically,
a negative ion will be accelerated towards the generator, stripped of its electrons, and
then repulsed away to double its energy.
Figure 3.3: An example tandem accelerator [78]
3.1.4 Limitations of electrostatic acceleration
As briefly, mentioned both the Cockcroft Walton generator and Van de Graaff acceler-
ator are both limited by corona breakdown, where air surrounding the electrode breaks
down and discharges the electrode and arcs are generated. This limits the maximum
voltage that can be generated which is approximately 1.5 MV in air. Highly charged
surfaces also have limitations due to the amount of charge that can be stored in a
material. To maximise the potential on the surface of the material its composition and
finish are extremely important, which is why the Van de Graaf generator is a sphere; as
charge will collect at sharp points [73]. Increasing the size of the sphere allows the col-
lection of more charge on the surface. Changing the pressure of the environment where
the generator is used can improve and increase the voltages achievable. Combining
these properties have generated potential differences up to 40 MV [79] [80].
3.2 RF acceleration
The development to achieve greater particle energies beyond electrostatic acceleration
came from radio frequency acceleration, where an electric field is coupled to a sinusoidal
RF source. Each half wavelength, the polarity of the voltage changes, and Wideroe
developed an accelerator which increases the energy at each crossing of the field. Known
as a linear accelerator (or linac), the design shielded particles from the electric field
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inside electrodes exposing the particle to the electric field in the gaps between. The
voltage experienced by the particle when traversing the gap is shown in Equation 3.2
V = V0 cos(φ) (3.2)
Where V is the voltage experienced by the particle, V0 is the peak voltage and φ is
the RF phase. The energy by the particle is dependent on its charge and the voltage
experienced when crossing the gap, is shown in Equation 3.3
E = qV (3.3)
Where E is the energy gained by the particle, q is the charge of the particle, and
everything else is as previously described.
When accelerated, the particle gains energy and travels faster. If the electrodes
were equidistant, as the particle energy increases, it would arrive before the voltage has
switched polarity; out of phase. To counteract the time difference, Wideroe increased
the length of the electrodes so the particle arrived at the centre of the gap at exactly
each half wavelength. The development of the linac allowed acceleration to high energies
using small voltages, as long as the drift lengths remained half a wavelength apart. This
however becomes a dis-advantage as the space needed to accelerate for a given energy
scales by a factor of 2 each time. Another disadvantage with linacs is that each RF
section can only be used once, so the design is somewhat inefficient.
3.3 Classic cyclotron
The classical cyclotron was designed by Earnest Lawrence in 1932 and accelerated pro-
tons to 80 keV, Figure 3.4 [14] [81]. The concept of the cyclotron uses RF acceleration
with an RF frequency that matches that of the machine known as the cyclotron or fun-
damental frequency. By placing two accelerating gaps 180◦ apart from one another,
as the particle reaches the centre of the gap, the polarity of the voltage is switched
accelerating the particle across each gap. Particles are accelerated in the centre of two
semi-circle electrodes, identified as dees because of their shape resembling the letter D.
Above and below the dees are the two magnetic field poles, which create the uniform
magnetic field in the centre of the electrodes. When a charged particle moves through
a magnetic field, it experiences a force,
F̄ = q(Ē + v̄ × B̄) (3.4)
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Figure 3.4: Earnest Lawrence’s cyclotron in 1932 [14]
where F is the force in Newtons, q is the charge of the particle, B̄ is the magnetic
field in tesla and v̄ is the velocity of the particle. This shows that for a charged particle
moving through a magnetic field will experience a force orthogonal to the magnetic field
and velocity, hence placing a particle with mass m and charge q in a uniform magnetic
field the particle will follow a circular path. Similarly, the force of particle traversing a





Where r is the particle radius and v is the magnitude of the velocity. Rearranging
Equation 3.5 describes the particle motion by the radial distance and the strength of








where p is the momentum of the particle. This gives a measure of how difficult it
is to bend a beam at a given moment.
In a circular motion one can also describe the revolution frequency or Lamor fre-





Equation 3.7 can be combined with Equation 3.5 showing that the revolution
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frequency for a particle in a uniform magnetic field is completely dependent on the
charge to mass ratio. Equation 3.8 is a fundamental property relevant for all circular
accelerating machines, however this is only correct for non-relativistic particles, where





There is also a relationship for the kinetic energy of the particle from its radius and












Figure 3.5: A figure taken depicting the concept of weak focusing for different field index,
n K. Strijckmans(2001)
Theoretically the particle will travel around the cyclotron exactly on the midplane
of the desired magnetic field. However, small imperfections or misalignment errors will
cause deviations in both the horizontal and vertical directions. Without restoring forces
to keep the particle on the equilibrium orbit, collisional losses with the electrodes will
occur. These restoring forces come from a radial variation of the magnetic field, by








With no magnetic field gradient, the field index is equal to 0, and in the perfect
cyclotron, particles will not collide with the boundaries of the accelerator providing
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they remain on the equilibrium orbit; as described in Figure 3.5.
If the field index is greater than 0, the magnetic field weakens as a function of
radius, and the poles are bent outwards This changes the field lines of the magnet, and
restoring forces are introduced towards the midplane of the accelerator, correcting any
axial particle movement in the accelerator. Alternatively, if the field index is less than
0, the axial forces move the particle away from the equilibrium orbit of the accelerator
achieving the opposite desired effect. From this it is therefore necessary to have a field
index greater than 0.
As the energy of the particle increases it will start to approach speeds comparable
to the speed of light, and relativistic effects will need to be considered. As a particle
becomes relativistic its mass increases by a factor of gamma, known as the Lorentz
factor; Equation 3.11








where c is the speed of light, v is the particle velocity and β is the ratio of the
particle speed to the speed of light.
Reducing the magnetic field keeps the orbit central axially, but radially the outcome
is different. The magnetic field needs to be increased radially to keep the particle
isochronous because of special relativity, hence negative field index is required. As the
field index exceeds 1, radial stability will not be achievable. To achieve restoring forces
in both planes it has been deduced that the field index n needs to be between 1 and 0
for a classic cyclotron.
Eventually special relativity will increase the mass of the particle and reduce the
orbit time, making the particle lose synchronicity with the phase of the RF system, and
eventually become nonsynchronous. The effects of relativity limit the classical cyclotron
as the magnetic field and the voltage RF frequency are constant, changing either the
frequency, the magnetic field or both must be used to counteract the relativistic effects
and keep the particle isochronous.
3.4 Isochronous or AVF cyclotrons
To isochronously accelerate particles into the relativistic regime, a radially varying field
needs to be introduced, B(r). The additional magnetic field strength needs to match the
increase in particle mass introduced by relativity necessary to maintain synchronism; as
described by Equation 3.12 .The additional magnetic field is achieved by multiplying
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the magnetic field at r = 0, B0 with the gamma factor γ, as described in Equation
3.11
B(r) = γB0(r) (3.12)
As discussed in 3.3, this corresponds to a field index requirement to less than 0,
which is beyond the constraints for vertical focusing. Isochronous cyclotrons, also iden-
tified as Thomas cyclotrons or azimuthally varying field (AVF) cyclotrons, introduce
the extra axial forces necessary by creating alternating azimuthal variations in the mag-
netic field. The alternating magnetic field strength is achieved by shaping the magnetic
poles and the different regions are referred to as hills and valleys; A hill describing a
stronger magnetic field, and a valley a weaker magnetic field as described in Figure
3.6.
Figure 3.6: a) shows the visible hills and valleys in an isochronous cyclotron, and b)
shows the magnetic field amplitude as a function of azimuthal angle [82]
The introduction of hills and valleys changes the trajectory of the particle, and is no
longer circular. The trajectory of the particle becomes scalloped because of the reduced
bending in the valley sections. The resultant orbit is no longer circular, and the shape
represents the number of sectors in the machine, where a sector consists of a hill and a
valley. The repetition of hills and valleys introduce Thomas focusing. Thomas focusing
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is described by the flutter, F, the quantification of the variation of the magnetic field





Where Bhill is the magnitude of the magnetic field in the hill, and Bvalley is the
magnitude of the magnetic field in the valley. In order to maximise the field variation,
the valley segments of the AVF cyclotron were reduced as much as possible before being
removed completely, introducing separate sector cyclotrons.
3.5 Betatron motion and tunes
As previously discussed, the ideal particle will travel exactly around the midplane in the
radial and vertical position; known as the stable equilibrium orbit. Realistic motion
however dictates that the particle will oscillate around the stable equilibrium orbit,
caused by the restoring forces in each plane.
The first accelerator to introduce restoring forces conceptually was the betatron,
hence the oscillations around the stable equilibrium orbit are known as betatron os-
cillations, and the movement of the particle is known as the betatron motion. The
betatron was developed by Max Steenbeck, but not built until 1940 by Donald Kerst
[83]. Electrons are limited in a cyclotron because of relativity, so alternative meth-
ods were explored for high energy electron beams and x-ray generation. A betatron
consists of a vacuum torus encased by an electromagnetic field. Like a cyclotron, the
radial orbit is maintained by the magnetic field, and the electrons are accelerated by an
external electric field. The electric field in a betatron is generated by induction, like a
transformer, except in this case the electrons in the vacuum torus act as the secondary
coil. As the electrons gain energy the magnetic field is increased to maintain the same
orbit, and weak focusing introduced to restore particle deviation from the midplane.
The number of particle oscillations per single turn is called the tune, Q [82]
The radial tune in a classic cyclotron is shown in Equation 3.14 [82], and the















where Qr is the radial tune, ω0 is the stable equilibrium orbit frequency, ωr is the
radial betatron oscillation frequency, n is the previously identified field index, Qz is the
vertical tune and ωz is the radial betatron oscillation frequency. With the additional
focusing for the isochronous cyclotron, necessary to satisfy the field index constraints,








Resonances in betatron oscillations can occur when a coupling between the vertical and
horizontal becomes apparent, identified by Equation 3.17
l = mQr + nQz (3.17)
Where l, m and n are integer values. The order of the resonance is identified by
the sum of |m| + |n|. Equation 3.17 can be interpreted visually by what is known
as a tune map, and the resonances are represented by lines. The particles tune can
also be represented on a tune map for a given energy, which is known as its working
point. The working point can be plotted for different energies across the accelerating
regime, which may vary with energy. If the working point moves across the accelerating
regime, it can potentially cross resonance lines on the tune map, which may amplify
particle oscillations and cause beam losses. Resonance crossings are more destructive
at lower orders, typically 1st and 2nd, and are avoided when designing an accelerator.
Higher order resonances are less destructive and crossing them can be tolerated, however
crossings should be completed quickly and ideally perpendicular to the coupling to
minimise beam deterioration, as this is the quickest way to cross a line. The way a
particle moves on a tune map can be manipulated when designing an accelerator by
changing its magnetic field profile.
3.6 Synchrocyclotron
The alternative to changing the magnetic field to counteract the relativistic mass in-
crease is to decrease the operational RF frequency of the cyclotron during acceleration.
This has both advantages and disadvantages in comparison to isochronous and classic
cyclotrons. Because the frequency is changing, only one particle bunch can be accel-
erated at any given time, and the beam is not continuous. The RF system can use
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one dee, smaller voltages and the accelerating gaps can be much smaller, and higher
energies can be achieved at the cost of many more turns in the accelerator [82]. Con-
sequently, the beam current is much lower, and as other accelerators were developed
and could achieve these energies with higher currents, the synchrocyclotron became
less popular.
3.7 Synchrotron
The synchrotron was developed from the issues encountered with relativity in the cy-
clotron. Where in a cyclotron the variation in magnetic field is completed as a function
of radius, spatially, the synchrotron changes the magnetic field as a function of time.
The RF used is also time varying like the synchrocyclotron, hence the same orbit can
be used to accelerate particles. Discovered by Vladamir Veksler in 1945 [84], at the
time this was significant development, as magnet and vacuum size could be decreased
making the accelerator more cost effective. The synchrotron introduced strong focus-
ing, which uses magnetic deflection with quadrupoles in order to focus the beam. It is
only possible to focus the beam in one plane at a time, which defocuses the beam in
the other plane. The effect can be reversed by using another quadrupole that is rotated
90◦ and the focusing and defocusing planes are switched. It was however discovered
by having a calculated drift between the two quadrupoles an overall focusing effect
is achieved. This layout is depicted in Figure 3.7 known as a FODO arrangement -
focusing drift defocusing drift. In Figure 3.7 the beam path is shown in red, the beam
envelope is shown in blue and the focussing ⁄defocussing magnets in black identified
by QF and QD respectively.
Figure 3.7: A depiction of the FODO lattice [85]
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3.8 Accelerators used for particle therapy
As discussed in Chapter 2 cyclotrons are the work horses of proton therapy where
approximately 2⁄3 of proton beams are delivered by a cyclotron [21]. Because they are
fixed field magnets, cyclotrons can be simply operated, making them easier to use in
a facility. However, cyclotrons are limited in that they extract at a single energy,
meaning to change energy the beam needs to be degraded. The consequence of beam
degradation for particles are the low secondaries produced, and the increased shielding
necessary because of it. Both Isochronous and synchrocyclotron exist as a method
of delivering proton beam therapy. Isochronous cyclotrons have both fixed field and
fixed frequency RF, making the operation much simpler, and a CW beam is delivered.
Consequently, one has to worry about orbit separation at higher energies, as discussed
earlier in this chapter. Synchrocyclotrons are more compact, but the change in RF
Frequency generates pulsed acceleration and treatment times become longer. Pulsed
acceleration does hold benefits over CW acceleration as extraction is easier and orbit
separation is less of a concern.
Synchrotrons are used for particle therapy and overcome the need for degradation as
they allow variable energy extraction. Consequently, like synchrocyclotrons they deliver
pulsed beams, and longer treatment times limited by the time dependent magnetic field.
The footprint for proton synchrotrons are also currently larger than cyclotrons, because
normal conducting magnets must be used, as it is difficult to vary the magnetic field in
superconducting magnets. With treatment time being longer, and the footprint being
larger, cyclotrons are generally preferred clinically [86].
Currently for ion therapy, only synchrotrons are used. Synchrotrons are used be-
cause they can be increased in size to compensate the beam rigidity necessary for
heavier particles, using smaller, weaker magnets. In a cyclotron this becomes difficult
as the magnetic fields and magnet size required to keep the machine compact are large.
3.9 Fixed Field Alternating Gradient (FFAG) accelera-
tors
A potential solution for ion therapy would be to use a Fixed Field Alternating Gradient
(FFAG) accelerator. The FFAG implements the combination of the fixed field time
independent magnetic fields from the cyclotron, and the alternating gradient from
the synchrotron. This allows fast acceleration of particles associated with cyclotrons
combined with the strong focusing and the potential for variable energy extraction from
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the synchrotron. [87]
Figure 3.8: The first FFAG at MURA in 1956 [88]
FFAG accelerators were first discovered in the 1950s by Symon [89], Ohkawa [90]
and Kolomensky [91] independently of each other. The first operational FFAG followed
in 1956; an 8 sector electron FFAG [92]. The concept of the FFAG was developed
throughout the 1960s by the Midwestern Universities research Association (MURA).
Several electron FFAGs were designed, the first constructed FFAG is depicted in Fig-
ure 3.8; a 400 keV electron design. However, the FFAG was quickly overlooked as
current research goals were driven towards high energy nuclear experiments, where the
synchrotron excelled. In addition to this the complicated 3D field calculation necessary
require high computational efforts, which at the time were not possible. The first elec-
tron FFAG magnets were completed on a mechanical calculator, the technical limitation
at the time [93]. The MURA group ended in 1963, and with this the development and
interest of FFAGs remained dormant until recently. With the advancement of technol-
ogy, FFAG accelerators have been studied for uses in many applications where large
particle energies are not necessary. For example, fast acceleration is necessary for muon
acceleration due to their short lifetime, and the desire for a neutrino factory inspired
people to think of the FFAG again[94] . With this and the computational development
over time came a refreshed interest in the FFAG. There are two design types of FFAG,
scaling and non-scaling (ns), and the initial focus was on scaling FFAGs.
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3.9.1 Scaling FFAG
The scaling FFAG is designed so that as the momentum increases radially the focusing
is the same, which means that each successive orbit of increased energy is a geometrical
enlargement of the previous. This means that a scaling FFAG has the same orbit shape
and optics at all energies but more importantly, the tune is constant for all orbits. To







Where By is the strength of the magnetic field, B0 is the magnetic field strength
at r0, the initial radial start point of the gradient, and r is the radius. The benefit
of the scaling FFAG allows the design of a fixed working point of the machine, but
consequently, this puts limitations on the size of the machine and acceleration. Obeying
the scaling law will dictate the radius of the machine as shown by Equation 3.18. The
acceleration is restricted in A scaling FFAG as it can only accelerate one bunch at a
time as the scaling law will not satisfy isochronous acceleration, hence variable RF must
be used. The use of variable RF will bear the same restrictions as a synchrocyclotron
and a synchrotron, limited beam current. However, the scaling FFAG has advantages
over its variable RF counterparts by having larger dynamic apertures, allowing larger
beam emittances and currents to be accelerated. When being directly compared to
the synchrotron the scaling FFAG accelerates particles because of their fixed magnetic
fields.
3.9.2 Non-scaling (ns) FFAG
The nsFFAG relaxes the scaling law, which was first proposed by C. Johnstone in
1999 for the acceleration of muons [94]. The nsFFAG still has alternating gradient
focusing fixed magnetic fields, but the radial magnetic field gradient does not adhere
to the scaling law is completely customisable. The relaxed constraints on the radial
magnetic field profile allows greater flexibility with the machine design, but at the
sacrifice of a fixed working point. Without obeying the scaling law, the working point
will change across the acceleration regime, and the possibility of crossing resonance
lines is introduced which can be destructive to the beam. However due to the fast
acceleration of the beam in FFAGs, it is possible to minimise the resonant effects on
the beam by crossing the resonances quickly. Although one has to manage the working
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point of a nsFFAG during design, its size and magnetic field are no longer bound, and
the radial magnetic field gradient can be manipulated to satisfy design requirements
for isochronicity, as detailed in Section 3.4. Initial design work focused on achieving
isochronicity using a linear magnetic field gradient, where only transverse forces are
applied to the beam, i.e systems that only use dipoles and quadrupoles. When obeying
the scaling law, the orbit circumference continually increases, however the relationship
between the orbit circumference in a linear nsFFAG follows a quadratic relationship
when the speed of the particle is approximately the speed of light. The parabolic path
length leads to a parabolic time of flight, however the variation of time of flight at the
vertex is sufficiently reduced the particles can be accelerated by fixed frequency RF
[95].
Using a magnetic field beyond the 2nd order makes a system non-linear, where
forces act on the transverse plane. Typically, in non-linear systems 3rd order magnets
known as sextupoles are used, which correct for chromaticity, the effective tune spread
caused when particles focused by a quadrupole experience different focusing based on
their momentum. Using non-linear field components allows the magnetic field to match
the time of flight more appropriately to γ. Improving the overall isochronicity of the
machine will minimise the phase slip, and make the accelerator more accommodating
to magnetic field errors and increasing RF harmonics, which will be discussed later in
Chapter 6. If the isochronous condition is matched sufficiently fixed RF can be used
to accelerate the beam, and CW acceleration becomes possible. nsFFAGs have the
potential to deliver high energy and high current CW beams beyond the capabilities
of current isochronous cyclotrons. Higher energy CW beams are desirable for particle
therapy, higher currents are desired for more efficient isotope production and high
energy, high current beams are well suited for the requirements of accelerator driven
sub critical reactors (ADSRs).
3.9.3 Current scaling FFAGs
The first FFAG designs were all electron scaling FFAG type accelerators, but the revival
brought the first proton FFAG in 2000, also of scaling design. The first FFAG was
constructed in the High Energy Accelerator Research Organisation, KEK (Kō Eneruḡı
Kasokuki Kenkyū Kikō). This design was a proof of principle machine, named POP
based on its purpose, and was the first of many FFAGs to be built in Japan. The
motivation for POP was rapid acceleration combined with a large acceptance making
them suitable for Muon acceleration. POP successfully accelerated protons from 50
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keV to 500 keV and is a radial 8 sector FFAG, roughly 2m in diameter. POP is
depicted in Figure 3.9a [96].
(a) The POP FFAG at KEK, Japan [88]
(b) the 150 MeV proton FFAG at KEK, Japan [97]
Figure 3.9: The first two Japanese FFAG accelerators designed and built in KEK
Due to the successful nature of POP, in 2003 another scaling FFAG was built at
KEK, accelerating protons from 12 MeV to 150 MeV. To achieve the 12 MeV injection
energy, a nested cyclotron inside the accelerator that feeds the FFAG. This design also
uses a triplet configuration but was designed in such a way where a yoke was not
necessary. This magnet design allowed more room for injection and extraction. The
accelerator is depicted in Figure 3.9b and is roughly 10m in diameter.
3.9.4 Current nsFFAGs
There has only been one nsFFAG built, EMMA (electron machine for many appli-
cations) at Daresbury laboratory, UK [98]. EMMA was a proof of principle linear
nsFFAG. The lattice was built using 42 straight sections, each containing a defocus-
ing and a focusing quadrupole [99]. each successive quadrupole was slightly offset to
provide the bending element, removing the need for dipoles. EMMA successfully accel-
erated electrons from 10 MeV to 20 MeV and demonstrated the concept of nsFFAG
accelerators. EMMA also demonstrated the crossing a first order resonance fast can
avoid the destructive betatron resonant growth and allow the beam to survive. EMMA
was approximately 5m in diameter in size and is depicted in Figure 3.10.
3.9.5 FFAG designs for charged particle therapy
Currently there are no FFAGs built for ion beam therapy, however there are FFAGs
that have been designed for this purpose but never implemented. One of the most com-
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Figure 3.10: An image of the EMMA accelerator [100]
plete designs would be PAMELA, Particle Accelerator for MEdicaL Applications. The
PAMELA design originated from a scaling FFAG, whilst slowly violating the scaling
law, and is categorised as a non-linear nsFFAG, as up to decapole field elements are
used. The design itself is 2 concentric ring accelerators, with 12 sections each. The
inner ring of PAMELA accelerates Protons and for therapy up to 250 MeV/u and
carbon ions up to 68 MeV/u. The outer ring further accelerates carbon ions up to
400 MeV/u, the necessary energy to reach 30cm tumour depth. The outer ring of
PAMELA had a diameter of 18.4m, taking up approximately 250m2 of space, which is
approximately a third less space than the current synchrotron models. The design was




The work in this thesis is completed using two computational codes. This chapter will
briefly discuss the two computational codes used and how they are used in this thesis.
4.1 COSY infinity
The first code used in this thesis is COSY Infinity [102]. COSY infinity is a scientific
computing program developed at Michigan State university. COSY infinity combines
transfer map with differential algebra to compute high order Taylor maps for a system.
For closed repetitive systems this provides very efficient computational power, as only
one map needs to be generated for the system which is then extrapolated using Taylor
expansion. The efficiency of the code is also clear when comparing to other different
types of computational solutions, for e.g ray tracing codes, which track an individual
particle in steps around the system until it terminates. This makes COSY a versatile
tool when simulating particle accelerators, being able to handle the higher order mag-
netic field and complex magnet design which in the past has stalled the development
of FFAGs.
4.1.1 FACT
In this thesis access to COSY was via a purpose built graphical user interface (GUI)
called FACT, developed by Carol Johnstone and Pavel Snopok. This utilities the
object orientation of COSY and allows simple construction of multifunction magnets
specifically for FFAG design. The capabilities of FACT however are limited, and it
is not possible of accelerating particles, so the code is only used for computation of
magnetic fields for lattice design.
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The input into FACT contains positional details for each magnet from a coordinate
system and its corresponding radial magnitude of magnetic field. The radial magnitude




bn × rn (4.1)
f(r) is the the magnitude of the magnetic field for a given radius r, n refers to the
order of the magnetic field, and bn is the magnetic field at r = 0 for each input magnet.
The magnetic field changes radially, and its radial magnitude is the summation of the
different orders of magnetic fields selected to create a custom radial gradient. Each
order of magnetic field can be adjusted as a function of radius by choosing its starting
value at r = 0 for each defined magnet in the design. Because of the hill and valley
sections, naturally the field gradient also varies azimuthally.
FACT has the ability to extract a field map from the input design, which can then
be used in other computational codes. The output field map is known as the median
plane field map, where the magnetic field map is presented in terms of the vertical
magnetic field Bz at z=0 for given x and y co-ordinates.
The lattice put through FACT then solves the equations of motion for an approx-
imate energy, and is able to find stable equilibrium orbits for a given energy. From
the transfer map created from the magnetic field profile the code iterates the radial
starting position for a given energy, until it achieves a closed orbit, using the Runge
Kutta iteration method. By increasing the particle energy in increments many stable
equilibrium orbits can be calculated along the acceleration regime.
From each computed stable equilibrium orbit the path length travelled by the par-
ticle is calculated. Knowing the energy and the path length, the ToF can be calculated,
and the isochronicity across the acceleration regime assessed.
To calculate the ToF the Lorentz factor γ is calculated for each energy using equa-
tion 4.2. The Lorentz factor can be rearranged and interpreted as a velocity using
equation ( 3.11) , hence knowing the velocity and path length the ToF can be calcu-
lated.
γ = E/E0 (4.2)




In order to accelerate particles, RF will need to be introduced, and second code will be
required. This also allows the results from COSY to be be compared and verified, and
OPAL was selected to do this.
OPAL (Object Orientated Parallel Accelerator Library) , developed and maintained
at the Paul Scherrer Institute (PSI). Based on the MAD language, OPAL was Built
from the ground up as a successor to MAD9P and designed to be a fully parallel
particle in cell (PIC) code capable of full 3D space charge calculations. Being fully
parallel allows OPAL to take advantage or parallel processing, and hence be utilised by
high powered computing. There are two flavours of OPAL; OPAL-cycl and OPAL-t.
OPAL-cycl focuses on cyclic machines, whereas OPAL-t is designed for the development
of beamlines, linacs and x-ray free electron lasers.
OPAL was selected, as opposed to specialist FFAG codes like Zgoubi, as OPAL can
read a varied amount field maps from different programs like COSY. A field map cannot
be easily inserted into zgoubi and requires a large amount of pre-processing. Only the
OPAL-cycl flavour will be used in this thesis, and due to the low currents necessary
for particle therapy, space charge effects will be negligible and turned off to speed
up computational time. The co-ordinate system in OPAL uses y as the longitudinal
direction, x is the radial direction and z is the vertical direction.
The output field map from FACT can be directly fed in OPAL-cycl and converted
into a cylindrical co-ordinate system (r, θ, z) within OPAL. In order for OPAL trajec-
tories that extend beyond z=0 it requires a magnetic field across the z plane. OPAL
achieves this by a 3rd order expansion of the field in the cylindrical co-ordinate system
as shown in equation 4.3. As the field is expanded it has limitations as the accuracy


















Where Cr, Cθ and Cz are the partial differential coefficients. OPAL solves the
Lorentz equation 3.4 in the time domain using a collision less vlasov equation. The
collision-less vlasov equation is a differential equation that describes the time evolution
of the distribution function of a plasma consisting of M charged particles, where E and




















Initial characterisation of beam
optics for nsFFAG designs
This chapter covers the design, optimisation and development of the field parameters
for a helium non-scaling Fixed Field Alternating Gradient accelerator (nsFFAG). Op-
timisation will be completed using the two codes of choice, COSY infinity [102] and
OPAL [104]. COSY infinity is operated through FACT, a specialised GUI for the COSY
infinity code, developed by C. Johnstone and P. Snopok [105]. Initial field parameters
provided by C. Johnstone [106] are inserted and optimised using FACT, to produce
stable equilibrium orbits for a given particle energy. Once the stable equilibrium orbits
are found, the time of flight (ToF) and working point or tune are identified for each or-
bit across the desired energy range, and the isochronicity profile assessed for suitability
for for fixed frequency acceleration. Once the ToF and tune results are acceptable, the
results are then compared to OPAL.
The importance of fixed frequency RF acceleration has been discussed in Chapter
3, and its consideration is the centre point to the initial design of the machine. This
means that the entire acceleration regime needs to be isochronous enough to allow fixed
frequency acceleration. Using a fixed field is not an issue in the non-relativistic regime,
as the mass of the particle is constant. Once one enters the relativistic regime and begins
to approach the speed of light, the particle begins to increase in mass. The increase in
particle mass makes it necessary for a bespoke magnetic field gradient to compensate the
decrease in frequency, or to change the frequency as the particle accelerates. Ramping
the frequency as the particle gains energy complicates the operation of the accelerator,
making it more difficult to operate in a clinical environment, and is more expensive to
implement.
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5.1 Design parameters
An FFAG accelerator will be designed for the purposes of particle therapy; notably a
non-scaling design. A non-scaling design has been selected over a scaling design because
of the possibility of achieving isochronous acceleration, and greater compactness, but
at the cost of the stable working point, as detailed in Chapter 3. In Chapter 2
it was discussed how essential compactness is when introducing medical accelerators
in current clinical environments, and not ignoring the current size of particle therapy
facilities and the infrastructure challenges encountered. If the accelerator could fit in
a current medical linac bunker, 50m2 it would be more than sufficient. A non-scaling
design does not come without challenge as the tune stability is sacrificed for the size
reduction, and the azimuthal field gradient necessary will be challenging to optimise
and maintain isochronicity whilst minimising resonance crossings.
The custom azimuthal field gradient is optimised to accelerate He2+, a particle with
a charge to mass ratio of 1/2. This design, therefore, has the capability of accelerating
any particle with charge to mass of 1/2. An ion of great interest would be fully stripped
carbon ions (C6+) for an alternative ion treatment modality. Ionised molecular hydro-
gen (H+2 ) could also be accelerated and used as a tool for imaging; allowing treatment
and patient imaging from the same machine. The potential to treat and image using
particles will reduce errors currently imposed by translating plans from CT [26]. How-
ever, it will only accelerate these other species to the same energy per nucleon. The
design energy for helium ions is 900 MeV which translates to 225 MeV/u to achieve
30cm depth in tissue. For a single proton, 225 MeV/u is suitable for treatment, but
330 MeV/u is necessary to image a patient. The design energy of the machine will
need to exceed the design energy for helium to be able to image with dihydrogen, to
approximately 1300 MeV.
5.2 Field map optimisation
5.2.1 Initial map generation
The initial field and magnet parameters used are provided by Carol Johnstone, gener-
ated from a Mathematica script [106]. The script solves geometric and tune equations.
Due to the nature of the movement of the working point of nsFFAGs, the primary
objective of the Mathematica script is an attempt to stabilise the tunes. The output
from the script is provided, and from here optimisation begins. The output of the file
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is in the “Enge edge”format which identifies the accelerator by geometric layout and
azimuthal radial field strength. An Enge edge file is described in appendix A.
5.2.2 Optimisation using FACT
The software used to optimise the provided field parameters is FACT; a specialised GUI
for the COSY infinity code as discussed in Chapter 4. The provided accelerator field
parameters as discussed in 5.2.1, are formatted for immediate entry into the FACT
code. The input contains the information for a segment or cell of the accelerator and
COSY mirrors the rest of the map based on this information, as demonstrated in Figure
5.1.
FACT is able to find stable equilibrium orbits for a given energy. For each magnet
design, many stable orbits were identified using FACT across the acceleration regime.
By studying the isochronicity profile of the stable equilibrium orbits it is possible to in-
tuitively makes changes to the different orders of magnetic field to optimise the acceler-
ation regime within tolerances. Acceptable limits for isochronicity have been identified
for fixed frequency acceleration for the orbits frequency to be within 0.1% of the oper-
ating frequency. To minimise losses and maintain beam quality, the total phase spread
of the beam should be ≤ 40◦ [107]. The phase spread of the beam can be identified as
the total phase slip the particle experiences over the whole acceleration regime.
To satisfy the above criteria, a strict tolerance of ±0.1% of the mean ToF across the
accelerating regime will be implemented. Whilst making changes to the magnetic field,
the working point of the machine will move. It is important to consider the working
point when optimising for isochronicity, as resonance lines may be destructive to the
beam if crossed or the working point remains within proximity to resonance lines for
many turns. As the working point moves, it is inevitable that some resonance lines
may be crossed or approached. The working point and resonance crossings will be
investigated using FACT and OPAL in this thesis. Resonance crossings are an issue in
cyclotrons crossing the fixed resonance lines of different orders as described in Chapter
3. As the resonance order increases, typically after the 3rd order, the working point
can cross them with minimal emittance growth. For lower orders, if a resonance cross-
ing cannot be avoided growth can be minimised by crossing it perpendicularly and
as quickly as possible. Cyclotron tune maps regularly cross higher order resonances
without issue (typically 3rd order and above) but lower order resonances are avoided as
they are rapidly destructive to the beam. EMMA [98], the worlds first nsFFAG, demon-
strated that it is possible to cross a first order resonance if crossed fast, prohibiting the
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amplification of betatron oscillation growth.
5.3 FFAG design 1
The first FFAG design investigated here is a square FFAG design consisting of 4 cells,
provided by C. Johnstone [106]. Each cell contains a large multipole bending magnet
and a smaller defocusing wedge magnet, as depicted in Figure 5.1. The design has
a starting energy of 250 MeV up to the design energy of 900 MeV. The magnets
dimensions span from a radius of 2m to 7m, incorporating 2m straights between each
quadrant of the design, which appears to have a magnet in between them. These green
rectangular magnets observed at 0◦, 90◦ 180◦ and 270◦ are dummy magnets with no
magnetic field. The dummy magnets are required by the code to create straights and
satisfy the geometrical inputs of the code, and have no magnetic field. The purpose of
the straights is to ensure there is enough space for sufficient injection, extraction and
RF cavity insertion.
The isochronicity profile and the working point across the acceleration regime for
different energies were identified, and are displayed as the red points on Figure 5.2.
Based on the output data, the magnet parameters were optimised to flatten the ToF,
and an attempt was made to maintain the current working point. The difference
between the original provided parameters and the optimised parameters are portrayed
in red and black, respectively. The tunes before optimisation are stable, but the ToF
is an order of magnitude away from the acceptable tolerances for the isochronicity
necessary for fixed frequency acceleration. The magnetic field profile for each order of
magnitude was then optimised in an attempt to flatten the ToF profile, and maintain
the tunes, but consequently the tune working point changes dramatically. In this
optimised case the magnetic field profile was very different to the original design, in
order to achieve a flatter isochronicity profile. Even after the iterations it can be
observed that the ToF is not within the necessary tolerances and more so the tunes
are now not acceptable. Before the tunes moved locally around 3rd and 4th resonance
lines, whereas after optimisation, they cross a 1st order resonance once, a 2nd order
twice and 3rd and 4th order resonances many times.
The optimised field design parameters were reinserted into the Mathematica script
and many different field configurations were generated with different geometries, with
acceptable tunes. Figure 5.3 demonstrates some of the alternative geometries that were
optimised in the same way as discussed above. The exact details of these designs are
spared from this thesis, but the outcomes are identical to the above discussed design.
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(a)
(b)
Figure 5.1: nsFFAG accelerator layout provided by C. Johnstone. (a) The initial quadrant
to be mirrored to create the full accelerator. (b) The full accelerator geometry.
Major adjustments were necessary to the initial parameters which made the provided
tunes unstable and the isochronicity profile was never within the necessary tolerances.
There is an additional problem that these maps also started at around 200 MeV
and a pre-accelerator would be required at this point to reach these energies. Knowing
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(a) The Time of Flight for design 1
(b) The tune variation for design 1
Figure 5.2: A nsFFAG accelerator layout provided by C. Johnstone. On both Figures,
red represents the values before optimisation and black afterwards
at this point multiple acceleration stages are needed, it was decided to step aside from
this design and separate the study into two separate designs, which will be referred to
as stage 1 and stage 2. Stage 1 will aim to accelerate ideally from as low as energy as
possible, to as high as possible isochronously.
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Figure 5.3: Different accelerator layouts provided by C. Johnstone that were optimised
5.4 Stage 1 design
Other work in our FFAG collaboration looked at proton acceleration at lower energy
(design energy of 30 MeV) for isotope production, the accelerator was called the proton
isotope producer (PIP). The original design for PIP also originated from C. Johnstone,
which used a simpler design with no counter bending magnets or straights. The work
on PIP led to the idea to adapt this model and see if it could be used as the pre-
accelerator or first stage of acceleration for the helium accelerator. PIP accelerates
protons from 75 keV to 28 MeV and can already accelerate He2+ because the design
energy of the machine is in the very early stages of the relativistic regime. Up to this
energy the beam rigidity of He2+ is nearly identical to that of protons [108]. This will
not hold true when adapted, as the particles energy will reach the relativistic regime
and changes will need to be made; however, it remains a good starting point.
Initial steps of adapting this design began with increasing the radial geometry of
the bending magnets to extend the energy range of the machine; no other parameters
were adjusted. Figure 5.4 shows the ToF variation, relative to the mean ToF, for the
extended field map up to a radius of 3m. The stage one design holds the same issue
as PIP, where at the inner radii the fringe fields overlaps. This field overlap suppresses
the vertical tune, which can be observed in the tune map for both designs, and hence
the change in the ToF. The initial start energy was increased from 75 keV to 500 keV.
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Figure 5.4: Initial ToF results from extending the design radius of the Proton Isotope
Producer (PIP), a different FFAG design within the collaboration [108]
The increase in start energy was due to the adaptation of the magnetic field gradient
causing the fringe field overlap to increase, and a stable orbit could not be achieved
at such a low energy. After many iterations, the results are shown in Figure 5.5 with
some iterations in-between demonstrating the progression made with changes.
The same methods to optimise the initial design field parameters to improve the
ToF and tune were used to optimise this design. It can be seen overall the isochronicity
across acceleration regime is reasonable and within the desired limits, bar the initial
acceleration. The tune does cross an integer resonance because of this, but the crossing
is at low energy, and nearly perpendicular to the resonance line. Providing the energy
gain per turn is large enough, the slip will be overcome quickly, and significant emittance
growth and beam loss can be avoided.
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Figure 5.5: Isochronicity profile for Stage 1 (extended PIP) for various iterations detailing
the progression made
5.4.1 Stage 1 further development
Using the information in Figure 5.5, it is seen that this design can accelerate He2+
isochronously from 2 MeV to 250 MeV. However there a few changes could be made
to improve the isochronicity and extend the energy range of the machine further.
The mean ToF will be skewed by the large ToF variation caused by the inner radii.
The inner radii are affected by the fringe field overlap which has a detrimental effect
on the ToF and tunes, as demonstrated by the ToF at 0.5 MeV. Injection may still
be possible at 0.5 MeV, as the rapid change in ToF will cause a phase slip, but it
should be recoverable if the energy gain per turn is large enough. The initial phase slip
may also affect beam quality by increasing the total phase slip across the acceleration
regime. As a result, it may be more practical to increase the injection energy to 1
MeV. At this energy the fringe field overlap is considerably reduced, and hence the
phase slip. The reduced initial phase slip will accommodate for a greater phase slip at
higher energies, potentially extending the energy range of the machine, and should be
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Figure 5.6: Final optimised iteration of stage 1 (Extended PIP) tune map detailing the
movement of the working point of the machine
easier to overcome.
From the isochronicity profile the ToF changes gradually becomes slower as the
energy of the particle increases and reaches the tolerance of 0.1% at 250 MeV. The
reduction in ToF at higher energies could be counteracted by changing the physical
magnet angle of the design. Changing the physical magnet angle will affect the time
the particle will be influenced by the hill of the magnetic field in an orbit. A depiction
of the magnet angle can be found in Figure 5.7 The adjustment of the magnet angle
would complement the reduced ToF at larger radii and provide a larger bending radius
for the beam, whilst having a reduced effect at the inner radii of the design.
When optimising, a design energy limit is necessary, and 250 MeV was selected
based on the starting energy of the previously optimised racetrack designs. However, the
design energy could be increased from 250 MeV; 400 MeV being an ideal energy. This
energy was chosen based on the fact this would be 100 MeV/u, and this corresponds to
a depth of approximately 10cm in water. A 10cm depth in water is clinically relevant
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and has the potential for treating a range of shallow tumours, for example, paediatric
head and neck tumours. The radius of a 5-year-old boy is approximately 8.2cm [109],
accounting for the extra water equivalence for the thickness of the skull, a 10cm beam
should be sufficient to treat paediatric tumours. This would mean that stage 1 has a
potential to be used without stage 2.
The magnetic field gradient is now exceeding the limits of normal conducting mag-
nets, 2 Tesla, and the magnets will need to be superconducting to handle the magnetic
field. The use of superconducting magnets is not envisaged to be a problem, as 8 Tesla
is achievable with superconducting magnets, and the magnetic field strength does not
exceed 4 Tesla. With the increased magnetic field, the pole gap between the magnets
is thought to be too small, at 2cm, because more space will be needed to cool the mag-
nets. This would need to be increased to at least 4cm. Having achieved part of our goal
after many design iterations, it was decided to give the project a name: HEATHER,
HElium ion Accelerator for radioTHERapy.
5.5 HEATHER Stage 1 final design
Applying the modifications suggested in Section 5.4.1, the magnet wedge angle was
increased by 2◦ and the pole gap between the magnets increased to 4cm. The starting
energy was increased to 1 MeV and the design energy increased to 400 MeV. After
introducing the magnet angle and pole gap changes, optimisation was successful, and
a final design was reached. Figure 5.7 depicts the physical layout of the accelerator,
with an outer radius of 3.5m. The field gradient as a function of radius is shown in
Figure 5.8, with a peak field of around 4 Tesla.
OPAL, a charged particle code capable of 3D space charge, was used to verify the
results from COSY.
To calculate a ToF in OPAL, the stable equilibrium orbit for a given energy needs to
be identified. This is found by iterating the starting radius and angular momentum until
the particle survives, for which a thousand turns with minimal azimuthal deviation was
deemed sufficient. Once the stable equilibrium orbit has been found, a non-interfering
probe is inserted into the machine cutting the orbit perpendicularly. It is found that
each turn the particle passes the probe, the time is recorded. The average revolution
time is then calculated for each turn and used as the ToF for that energy. The final
design ToF is almost within the limits proposed earlier within this chapter. This means
it should be possible to begin acceleration at 1 MeV, but consequently with a small
phase slip. It is within the tolerances at 2 MeV, and this should be reached in less
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Figure 5.7: Final optimised geometry of stage 1
than 3 turns. The ToF for both COSY and OPAL are compared in Figure 5.9; they
show excellent agreement. The mean ToF for stage 1 is 99.067ns which translates to a
frequency of 10.0942 MHz.
OPAL is also capable of calculating the tunes, which it does by simulating 2 parti-
cles, the reference particle and a displaced particle. Fourier analysis is used to identify
the orbit difference between the two particles. The tunes were also computed and com-
pared to COSY, as illustrated in Figure 5.10. Vertical tune suppression is evident,
which causes the rapid ToF variation observed at lower energies. This does cause a 1st
order resonance crossing, however if this is traversed quickly it should not be detrimen-
tal to the beam. A greater concern may be the time spent near the 2nd order resonance
line, as it will take a few turns to surpass, and it may be enough to cause emittance
growth; this will be further investigated when a beam is accelerated in Chapter 6.
There is good agreement between both codes, however there is a slight disagreement
when the fringe fields become stronger. The disagreement could also be due to the
radial granularity of the field map produced from FACT for OPAL at smaller radii.
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Figure 5.8: The azimuthal magnetic field gradient for stage 1
The change in starting energy is much higher than the original 75 keV, and a
pre-accelerator will be necessary. Accelerating from source to 1 MeV is achievable and
has been demonstrated with protons at PSI from source to 870 keV before entering
the injector 2 cyclotron. The stage 1 design suggests that given enough energy gain
per turn, it should be possible to isochronously accelerate He2+ from 1 MeV to 400
MeV; or any other particle with charge to mass ratio of 1/2. This is beyond the original
foreseen scope of the 1st stage and may provide a standalone solution for helium therapy
without stage 2. This also is a very versatile option going into stage 2 as the exit energy
for stage 1 is higher. The increased exit energy allows for a lot more flexibility when
designing the start energy for stage 2.
The dynamic apertures were investigated in OPAL across the acceleration regime,
and the smallest acceptance was found to be approximately 20 πmm mmrad in the
horizontal and vertical planes.
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Figure 5.9: Stage 1 isochronicity profile from 1 MeV to 400 MeV comparing results from
FACT and OPAL
5.6 HEATHER stage 2 design
Having reached 400 MeV total energy, the next step was to increase this to 900 MeV.
To increase the energy the current stage needs to be modified or a new accelerator needs
to be designed. Rather than revisiting the designs discussed in 5.3 or starting a design
from scratch, a modification to Stage 1 was attempted to increase its energy range. The
concept of having a racetrack design is desirable to increase the availability of space,
stage 1 was redesigned with straight sections. Additional space created by a racetrack
design could be used to insert cavities, or to inject ⁄ extract the beam. As opposed to
increasing the existing gap between the magnets and rotating the design, it was pulled
apart and the straight inserted along the vertical axis. The physical construction of the
machine is still a thought when designing, and the idea is that all the magnets have an
identical field gradient to try and aid that process. Figure 5.11 portrays the concept
of putting the straight into stage 1. Note, as previously the green rectangles are not
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Figure 5.10: Comparison of the working point for stage 1 in FACT and OPAL
magnets, they are just necessary for the purposes of magnet geometry in the code.
One of the issues with the original design was the fringe field overlap, and the
addition of a straight would pull these orbits away from the inner radii, providing more
room for cavities, injection and extraction. Consequently, the footprint of this design
would be larger with the straight section, but it is still a reasonable size comparatively
and the accelerator should fit in current bunkers, as discussed in Chapter 2.
With the introduced straights the starting energy was expected to be higher because
of the increased path length. The lowest stable orbit for was sought after around 10
MeV, but a stable orbit could not be achieved until 30 MeV with a significant ToF
variation for this parameter configuration. Each iteration depicted in Figure 5.12
attempts to build on the issues of the previous iteration by adjusting the Bn values
described earlier in Equation 4.1. The iterations in Figure 4.1 alter the quadrupole
and sextupole component of the design, in an attempt to raise the ToF of the higher
energies As iterations of the design progressed the parabolic ToF could be improved,
but not enough to satisfy isochronous conditions up to 400 MeV to match the original
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Figure 5.11: A depiction of the concept of putting the straight into stage 1
idea, as highlighted in Figure 5.12.
It can be observed that steadier isochronicity is present over a higher energy range
from iteration d in Figure 5.12. From the first attempt at optimising this design, it
suggests Stage 2 could be viable to accelerate from 400 MeV to 900 MeV through
a second accelerator. From iteration d specifically the region from 250 MeV through
to 400 MeV which would be a great starting point for a second stage; it is relatively
isochronous and there are no issues with fringe field overlap. The focus then switched
to adapt the design to satisfy the requirements for a 2nd stage based on its isochronicity
profile; continuing the acceleration from 400 MeV to 900 MeV.
Based on iteration d in Figure 5.12, Initial iterations started at an energy of 200
MeV, as opposed to the 400 MeV achieved by stage 1. The decrease in starting energy
for stage 2 was based on the isochronicity profiles originally optimised, however the
design energy of 900 MeV has not changed. Figure 5.13 details further iterations
carried on from iteration d of Figure 5.12, but over the energy range of 250 MeV
to 900 MeV. As previously, Optimisation between successive iterations is achieved
by changing the magnitude of the magnetic field for different magnetic field orders.
The design demonstrates the potential to achieve the isochronicity profile within the
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Figure 5.12: A depiction of the concept of putting the straight into stage 1 for different
iterations of the design
necessary tolerances from 400 MeV to 900 MeV, but it was again difficult to contain
the parabolic ToF beyond the core requirements of stage 2, reducing the flexibility of
the design. This is unfortunate as a 200 or 300 MeV starting energy would reduce
the energy of stage 1, reducing its footprint. Figure 5.13 demonstrates that the design
is not sufficiently isochronous over the entire acceleration regime, where the green
band highlights the 0.1% boundaries for all configurations. The additional red band
was placed off zero demonstrating the isochronous potential that could be achieved by
beginning acceleration at 400 MeV. Starting at 400 MeV is an option, but consequently
would increase the footprint of the overall design, using the maximum footprint for stage
1.
Increasing the start energy to 400 MeV for the 2nd stage was found to be successful.
After many iterations the ToF is comfortably inside the isochronicity boundaries, and
the tunes are acceptable; no 1st or 2nd order resonances are crossed, only 3rd and 4th
order. The results shown in Figure 5.14 are from FACT.
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Figure 5.13: ToF profile for iterations for the energy range 200 MeV to 900 MeV.
(a) Isochronicity profile for Stage 2 v1
(b) Tune map showing the working point for Stage
2 v1
Figure 5.14: Stage 2 version 1 with an energy range from 400 MeV to 900 MeV
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5.6.1 Differences between stage 1 and stage 2
Although the latest iteration satisfied the necessary isochronicity and tune conditions
for stage 2, the overall goals of isochronous acceleration through to 900 MeV were
not met. The average ToF of 92.35 ns and corresponding frequency of 10.8286 MHz
does not match that of stage 1. The difference in frequency is too large and would pre-
vent isochronous acceleration over both accelerating regimes with the same frequency;
further optimisation is necessary to achieve this.
To attain isochronicity in both stages the revolution time for stage 1 needs to be
decreased, or the revolution time for stage 2 needs to be increased. Decreasing the rev-
olution time for stage 1 requires reducing the magnetic field, which would increase the
footprint as it would push the orbits outward. The Stage 1 fringe fields also complicate
the design at the inner radii which are currently manageable. Reducing the magnetic
field will reduce the strength of the fringe field, however a smaller proportion will be
affected by the fringe fields, and the ToF will have much more variation radially at the
inner radii. Stage 2 has more flexibility spatially and does not have overlapping fringe
fields complicating optimisation at the inner radii. To increase the orbit velocity for
stage 2 would require increasing the magnetic field strength, which would reduce the
footprint of the accelerator. It was identified changing stage 2 would be easier than
adapting stage 1.
5.7 Stage 2 final design
Stage 2 was further optimised, to match stage 1, and the average ToF was decreased to
99.079 ns. The mean ToF values between stage 1 and stage 2 are now within 1% of each
other; suggesting the possibility that a single frequency could accelerate He2+ through
both stages successfully. The final magnet layout and field gradient are depicted in
Figure 5.15.
The straights were inserted to aid injection and extraction however the gaps are
larger on the bends. It would be preferred to put the cavities in the straights and
complete injection and extraction in the gaps between the bending magnets. Having
the cavities in the straights helps with the optics because the design will be symmetrical.
In addition to matching the operating frequency for each machine, the overall ToF
variation relative to the mean for stage 2 was reduced by approximately 2/3 from
0.13% to 0.04%. The improved isochronicity is illustrated for both COSY and OPAL
in Figure 5.16. Both COSY and OPAL are in good agreement, however there is some
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(a) The magnet layout for stage 2 (b) Stage 2 custom azimuthal field gradient associ-
ated to all of the magnets
Figure 5.15: Stage 2 finalised physical parameters
slight variation between the two codes; this is negligible and believed to be down to
the computation of the field map because of the straights and field map granularity.
The working point also has some discrepancies between OPAL and COSY as seen
in Figure 5.17. The variance in working point between the two codes is also believed
to be caused by the same issues as for the ToF. Notably the tunes cross a 2nd order
resonance line initially but after this only 3rd and 4th order resonances are crossed.
There is a concern that the resonance crossing may cause emittance growth, but this
will not be fully discovered until the acceleration of particles are simulated, which will
be investigated in Chapter 6.
5.8 Chapter summary
In this chapter I have achieved the first steps in isochronously accelerating He2+, by
creating and optimising a two-stage accelerator with acceptable tunes and ToF across
both machines. The steps taken and progress made have been discussed, and the
initial design parameters met. The next steps in the design phase is to accelerate a
single particle through the machine, which is discussed in the next chapter.
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Figure 5.16: The isochronicity profile across the acceleration regime for stage 2 comparing
COSY and OPAL
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Figure 5.17: The tune diagram showing the working point for stage 2, comparing results
from COSY and OPAL.
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6
Acceleration studies and RF
Characterisation
This chapter covers single particle acceleration through stage 1 and stage 2 for HEATHER.
In the previous chapter, stable equilibrium orbits were calculated across the desired en-
ergy regime for both stages 1 and 2. From the stable equilibrium orbits, the time of
flight (ToF) was calculated and the isochronicity compared and discussed in two parti-
cle tracking codes. Adjustments were made to ensure the ToF for each stage is as close
as possible, in order to operate with fixed frequency acceleration across both stages.
The difference in frequency between the stages was achieved to within 1%.
This chapter will place RF accelerating structures within the accelerator designs for
both stages and identify the optimal operating frequency to be used across both stages.
Once the operating frequency is identified, the injection parameters will be optimised
to achieve ideal accelerating orbits. RF systems in current operation in separate sector
machines, alongside the voltage thresholds proposed by the Kilpatrick limit, will be
used to identify and suggest RF parameters achievable with current technology. These
parameters will then be simulated using OPAL and conservative realistic parameters
selected to be used when one begins to accelerate beams of particles. This will help to
show that the design is feasible beyond a theoretical stage (or concept).
6.1 RF in Cyclotrons
Electrodes called dees were originally used to accelerate particles in cyclotrons, given
their name by their semi-circular shape resembling the letter ““D””. Two dees were
situated in the pole gap between the two magnets and a sinusoidal electric field gener-
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ated between them. This created two accelerating gaps, 180◦ apart, where traversing
particles gained energy as given in Equation 6.1
Et = 2qV0 cos(φ) (6.1)
Where Et is the energy gained in MeV per turn, q is charge, V0 is the RF voltage
in MeV and ϕ is the phase of the particle at the centre of the accelerating gap. The
factor of two appears because the particle crosses two accelerating potentials.
In a classical cyclotron, the ideal particle is perfectly isochronous; or synchronous.
The particle will arrive at the centre of the gap in perfect time with the alternating
voltage and experience no change in phase. If the particle phase is not ideal, it would
arrive early or late in time at the accelerating gap with respect to the synchronous
particle. A non-synchronous particle will become out of phase with the RF voltage,
as described in Equation 6.2, this changes the maximum kinetic energy the particle
receives from the RF system.
φ = ωtotal∆τ (6.2)
Where φ is the phase of the particle, ωtotal is the orbital frequency in MHz and ∆τ
is the difference in orbital time between the synchronous particle and the time of the
particle accelerated by the operating RF.
The difference in phase between the synchronous particle and the accelerated par-
ticle is known as the phase slip, and has a direct effect on energy gain as shown in
Equation 3.3. A phase slip will lead to a reduced energy gain per turn and increase
the overall time of the acceleration regime. Providing the particle phase stays within
-π⁄2 and π⁄2 whilst accelerating, it will receive energy from the RF system. Note that
with a consistent phase slip, the particle phase may exceed these boundaries, decelerate
and lose energy to the RF system. However, it is desired to keep the total phase slip
within 40◦, to avoid this and maintain beam quality. When the energy of the accel-
erated particle enters the relativistic regime, the particle’s mass increases, hence ∆τ
increases. To maintain fixed frequency RF, the accelerator must have a customised
azimuthal gradient to counteract the increased mass to maintain synchronism as dis-
cussed in Chapter 3. The FFAG design presented in this thesis will have a custom
azimuthal field gradient, and from the stable orbit analysis in Chapter 5, the opera-
tional RF frequency does not exactly match the synchronous frequency. As the ideal
particle will arrive early or late the resulting phase slip will need to be managed.
With the development of isochronous cyclotrons, hills and valley were introduced
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and which naturally led to separate sector magnet designs to increase the axial fo-
cusing term. Separate sector designs allow more room for beam instrumentation and
could cater for the insertion of RF cavities in the valleys of the machine. Separate
sector designs allow for more efficient acceleration as classically injection, extraction
and acceleration all had to occur at the dee gap. Separate sector designs have the space
to accommodate resonant RF cavity designs. Using separate sector machine designs
the number of RF structures could increase, providing more efficient and powerful RF
[110] [111]. HEATHER is a two stage separate sector design, therefore it is possible
and logical to use RF cavities as opposed to dees.
6.2 Kilpatrick limit
By using RF cavities in the design, multiple cavities can be inserted in to the accelerator.
This in turn means the particle sees more accelerating voltage, which is crucial for
increased turn separation. Turn separation describes the space in between successive
orbits radially for cyclic machines that vary magnetic field as a function of radius.
When extracting the beam, turn separation is an important parameter as typically
instrumentation will need to be placed between successive orbits. The orbit separation










Where R is the orbit radius, Ut/m0c
2 is the energy gain per turn and γ is the
Lorentz factor.
Cavity design is extremely complex, and a full detailed design is beyond the scope
of this thesis, but simple considerations have been made to imitate an achievable RF
structure. These considerations are the voltage used, the gap size and the harmonic
used; which can all be considered when investigating the Kilpatrick limit and discussed
below in detail. The Kilpatrick limit is based on empirical data taken by W.D. Kil-
patrick in 1957 [25], used to calculate the maximum electric field achievable for a given
frequency before RF breakdown occurs. RF breakdown occurs when breakdown voltage
is reached for an insulating material and it begins to conduct electricity; potentially
resulting in physical damage to the structure. The data was readdressed by T.J Boyd,
1982 [113] and represented by Equation 6.4.
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Where f is the frequency of the cavity, Ek is the maximum electric field achievable
on the material surface in MV/m. This can be solved for Ek for a given frequency, as
shown in the appendix, and as depicted below in Figure 6.1.
Figure 6.1: Frequency as a function of energy based on the empirical data by W D
Kilpatrick [25]
It can be observed that the breakdown voltage threshold increases as a function
of the square root of the frequency, hence higher frequencies yield greater acceleration
potential. The orbital frequency of the machine is a physical property and cannot be
changed, but the operating RF frequency can be operated at integer multiples of the
orbital frequency, known as harmonics.
6.2.1 Harmonics
The principle of RF in a classic cyclotron is the alternating electric field switches exactly
at the point when the particle crosses the accelerating gap. This is achieved by matching
the RF system’s operational frequency to the fundamental frequency of the machine. It
is also possible to operate the RF at an integer multiple of the fundamental operating
frequency, known as a harmonic, as expressed in Equation 6.5.
FRF = nF0 (6.5)
Where FRF is the RF frequency in MHz, n is the harmonic number, expressed as
an integer, and F0 is the operational frequency of the machine, or in this case the 1st
harmonic.
Operating at higher harmonics has a detrimental effect to the beam. Because the
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voltage is coupled with a sinusoidal frequency, as the harmonic increases, the amount of
time the particle is accelerated reduces, as there are n acceleration segments across the
accelerating gap. The reduced acceleration results in an increasing phase slip, resulting
in the effects as previously described above.
6.2.2 Transit time factor
The coupling of the voltage to an RF field makes the voltage time dependent, and the
particle speed will change as a function of position across the accelerating gap. The
time dependent voltage will have an effect on the energy gain of the particle traversing
the cavity and is taken into account by the transit time factor. The transit time factor
can be expressed as an additional term T in Equation 6.1, as shown in equation 6.6
Et = qV0T cos (ωt+ φ) (6.6)
Where t = 0 at the centre of the gap, and φ describes the phase of the RF field
relative to the crest. If we assume the velocity change across the gap L is negligible,













If we then substitute Equation 6.7 into 6.6 and integrate over the accelerating gap





The transit time factor may be interpreted as a contributor to accelerator efficiency.
Generally, the transit time factor decreases as a function of increasing gap size and
could be a concern if the accelerating gap increases. However, assuming a 10cm gap
and operating on 8th harmonic, both of which are unlikely for this work, the transit
time factor reduces to .995; which is negligible.
Using the Empirical data from Kilpatrick represented in Equation 6.4, the maxi-
mum frequency can be presented as a function of gap size, g, and consider the effect of













Using the solution for Equation 6.4 for Ek, the relationship for Ekmax the maximum
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MV/m for a given frequency and gap size can be established. The frequency was
interpreted as harmonics of the fundamental operating frequency and the gap size was
iterated from 1cm to 8cm in increments of 1cm, calculating the maximum voltage that
can be achieved before breakdown will occur. Figure 6.2 depicts the relationship
between the maximum voltage per gap size achievable at different harmonics for the
fundamental frequency of 10.0911MHZ.
Figure 6.2: Maximum surface voltage achievable before breakdown occurs for different
harmonics and accelerating gap sizes
It is important to note that the work of Kilpatrick was completed more than 50
years ago, and even then, it was noted that the Kilpatrick limit could be exceeded by
a factor of 2 or 3 by carefully treating the surface of the material. This factor is now
known as the bravery factor and will be ignored for the purposes of these simulations.
Ignoring the bravery factor and being conservative is beneficial if the desired results
can be achieved without these considerations. However, any increased voltage incurred
by the bravery factor will improve energy gain per turn and orbit separation, which is
only beneficial for the design.
88
6.2 Kilpatrick limit
6.2.3 Current separate sector machines and their RF
Having discussed the theoretical limits proposed by the Kilpatrick limit, it is important
to look at current working separate sector particle accelerators and identify what RF
parameters have been achieved and whether they could be suitable for this design.
There are several renowned separate sector cyclotrons around the world at estab-
lished facilities, the most recognised being at the Paul Scherrer Institut (PSI). As
depicted in Figure 6.3 PSI houses two separate sector cyclotrons in one system; in-
jector two and the ring cyclotron. The acceleration cycle begins from source to a Van
der Graff electrostatic accelerator accelerating protons to 870 keV. The accelerated
protons are then injected into injector 2, the first separate sector machine, and further
accelerated to 72 MeV in 100 turns. The 72 MeV protons are then transferred to
the ring cyclotron, the second separate sector machine, where the protons are further
accelerated to 590 MeV before being extracted from the system [115] [116] [117].
(a) Injector 2 [118]
(b) The ring cyclotron [119]
Figure 6.3: Separate sector cyclotrons at the Paul Sherrer Institut, Switzerland
Each separate sector stage in this system has its own RF system. Injector 2 acceler-
ates protons using 2 delta type half wavelength double gap resonators with a gap with
of 3.5cm and a gap voltage of 150 kVp, operating at 10th Harmonic at 50 MHz. There
have been recent upgrades to increase the beam current at PSI; which has resulted in
additional cavities present in injector 2; the addition of 2 single gap half wavelength
resonators. These additional cavities operate at identical parameters to the current res-
onators, but have an increased peak voltage of 400 kVp. The RF system for the ring
cyclotron operates at the same frequency, but single gap resonators are used instead of
delta type cavities. The ring cyclotron cavities have recently been upgraded. Initially
the RF voltage was set to 730 kVp but the upgraded cavities achieve 1 MV. The gap
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size cannot be found in the literature, but the cavity accelerating voltage is 8.8 MV/m
and operates on 6th harmonic. Using the Kilpatrick limit, one could estimate the gap
size to be around 10cm.
There are two established facilities in Japan that hold high energy ion separate sec-
tor accelerators, RIKEN and the Research Center for Nuclear Physics (RCNP). RIKEN
is a large multidisciplinary research centre which holds 4 separate sector accelerators
all connected to provide a multi stage accelerator for ions. The path of the particle
through the machines depends on its mass, as there are different acceleration regimes
for different ions. The four separate sector machines are identified as the RIKEN Ring
Cyclotron (RRC) (depicted in Figure 6.4a), the fixed frequency ring cyclotron (FRC),
the intermediate ring cyclotron (IRC) and the superconducting ring cyclotron (SRC)
[120]. Irrespective of operating mode a summary of the RF for all the accelerators are
taken from Sakamoto et. al [121] in Figure 6.4b.
(a) The RIKEN Ring Cyclotron (RRC), Japan
[122] (b) A table detailing the RF systems for the differ-
ent cyclotrons at RIKEN [121]
Figure 6.4: The RIKEN facility
There is a single separate sector accelerator at RCPN, the RCNP ring cyclotron. In
this system, an AVF cyclotron injects particles into a ring cyclotron, reaching a final
energy of 100 MeV/u . The separate sector design has 3 RF cavities, achieving a
maximum acceleration voltage of 500 kVp and operates at 6th and 10th harmonic.
All of the accelerators discussed thus far are specialist standalone accelerator fa-
cilities, however there are commercial proton therapy cyclotrons available. The most
popular commercial cyclotrons available from Varian and IBA.
Varian provide the ProBeam, an isochronous separate spiral sector cyclotron. This
machine accelerates protons to 250 MeV, using 4 half wavelength cavities [111]. These
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cavities operate at 72.8 MHz running on the 2nd harmonic, with an accelerating voltage
of 80 kVp. The Varian Probeam cyclotron was chosen by both of the NHS facilities
providing full energy proton beam therapy in the UK, as discussed in Chapter 1.
IBA currently provide proton therapy using their proteusOne solution, which ac-
celerates particles using their superconducting synchrocyclotron (S2C2). Because it is
a synchrocyclotron, it corrects for relativity by reducing the RF frequency, hence only
pulse will be present within the cyclotron at any given time. As discussed in Chapter 3,
the energy gain per turn is not a priority as the machine is not CW and the RF design
is somewhat irrelevant to HEATHER. Nevertheless, for completion, the accelerating
voltage is 3-12 kVp operating at 1st harmonic.
It can be seen that the high energy separate sector accelerators use single gap
cavities where the voltage across the gap typically ranges from 400-800 kVp. Smaller
machines used as a pre-accelerator in a chain typically use delta type half wavelength
double gap resonator cavities, to achieve similar voltages, ranging from 100-300 kVp.
6.3 HEATHER RF Studies
For Stage 1, two delta type half wavelength double gap resonators will be used, using a
gap voltage of 300 kVp. The feasibility of this design depends on using already existing
technology, and a 300 kVp has already been achieved using a delta type double gap
resonator and single gap resonators. The RIKEN cyclotron uses delta type double gap
resonator at a slightly lower frequency of 45MHz for the desired gap voltage and the
single gap resonators used at PSI achieve 850 kVp operating at 50MHz; 300 kVp
should be realistically achievable.
To achieve 300 kVp, the gap size needs to be at least 4cm based on the Kilpatrick
criterion. The Kilpatrick limit does not have any restrictions on frequency necessary to
achieve 300 kVp, but the cavity size is dependent on frequency. To achieve a realistic
cavity size (in terms of civil engineering) the cavity needs to be less than 3m, hence
the 5th harmonic should be the minimum used, if achievable by the machine.
For stage 2, single gap resonators will be used as in all high energy cyclotrons, such
as PSI. The cavities used at PSI are a great example of what could be used, but to be
conservative, 500 kVp will be used as opposed to 850 kVp.
6.3.1 HEATHER RF operating frequency selection
Before optimising the cavities for each stage, a single operating frequency needs to be
established across both stages. For stage 1 two simple uniform single gap RF cavities
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Figure 6.5: Highlighted magnet and cavity dimensions for stage 1 and stage 2 of
HEATHER
with a width of 1cm were added 180◦ apart; at 45◦ and 225◦ in between the magnet
gaps as depicted in Figure 6.5. The accelerating voltage across the gap is uniform
radially with a voltage of 300 kVp. For stage 2, identical RF accelerating gaps are
inserted into the straight sections; but with an increased accelerating gap voltage of 500
kVp. The positioning of the cavities for stage 2 is depicted in Figure 6.5 contradicting
the initial purpose of the straights: to aid injection and extraction. This is because at
the outer orbit the distance between the sector magnets is greater than the 1m straight
allowing more room to extract, as depicted in Figure 6.5, and it makes the optics more
symmetrical.
Using the mean synchronous frequency for each stage as a starting point, the op-
erational fixed RF frequency was identified. A single fully stripped He2+ particle was
accelerated from 1 MeV to 400 MeV for stage 1 and from 400 MeV to 900 MeV
for stage 2. The total phase slip across the accelerating regime for different frequen-
cies was calculated to identify the ideal operating frequency for each stage. Because
neither stage is perfectly isochronous a phase slip will occur. Minimising the phase
slip allows for maximum kinetic energy to be transferred across the whole acceleration
regime; reducing the beam time in the machine and the risk of losses. Figure 6.12
shows the particle phase acceptance during acceleration for both stages, and Figure
6.6 shows the calculated phase slip from the shown frequencies and compared for both
stages. The optimal fixed RF cavity frequency for stage 1 and stage 2 were found to
be 10.0911 and 10.0919 MHz respectively. This is different to the mean synchronous
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Figure 6.6: The largest phase slip measured across the acceleration regime for different
RF frequencies for stage 1 and stage 2
frequency as predicted because the energy gain relative to the beam energy is much
greater at lower energies, and the phase slip can be overcome at a faster rate. This is
especially important for stage 1, where the fringe fields overlap and the vertical tune
is suppressed at low energies, causing an integer resonance crossing. Using a 300 kVp
voltage per gap for stage 1 translates to a 2.4 MeV peak energy gain per turn. The
vertical tune suppression is overcome at around 20 MeV, as depicted in Figure 5.10,
where the energy gain at this point is greater than 10% per turn. As demonstrated
with EMMA [98], crossing the integer fast enough is not detrimental to the beam,
which is also demonstrated here. Stage 2 has two single gap resonant cavities and gains
2 MeV per turn. It crosses a 2nd order resonance initially, which may be an issue, due
to the relative energy gain comparative to the initial crossings with stage 1.
To operate at the same fixed frequency across both stages, a compromise must be
made between the two machines, as they both have different optimal RF frequencies.
From the range of frequencies simulated the optimum operating frequency for both
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machines was found to be that of stage 1, 10.0911MHz. When comparing the two
stages, stage 2 is more isochronous, and less effected by a phase slip than stage 1. This
can be observed in Figure 6.6. Because stage 2 is more isochronous it is possible to
use an RF frequency optimal for stage 1, and in this case, achieve a smaller total phase
slip for stage 2.
6.3.2 Optimisation of the acceleration orbit
The ideal acceleration orbit or beam centroid is a reference orbit which perturbations
can be compared against. The ideal orbit chosen for these machines is where the orbit
separation between two sequential orbits are as equidistant as possible, also known as
centering. As well as frequency and phase slip as discussed, the orbit radius, angular
momentum, injection angle, and starting phase are variables that effect the ideal accel-
eration orbit. The radius and angular momentum are important factors controlling the
orbit direction, as adjusted and discussed in the previous Chapter. These parameters
are iterated, and the orbit assessed to identify the ideal orbit. Because of the initial time
of flight variation for stage 1, it is important to accelerate immediately after injection to
pass this region rapidly and minimise beam growth and losses. Ideally injection would
be a few cm from the cavity but this is not realistically feasible. Considering space
may be necessary for injection, the particle injection angle is set to 30◦, just before the
cavity and halfway between the cavity and physical magnet edge. A visualisation of
the injection angle is shown in Figure 6.7
Stage 2 has much more space, and for the purposes of optimisation the beam was
injected directly 25cm away horizontally from the cavity. Because this design is a
racetrack, trigonometry was then used to identify the radius and angle when simulating.
In separate sector designs, the particle is not injected at the cavity; but in a valley. Its
starting phase is therefore important so when it meets the cavity it arrives with the
same phase as the cavity. Arriving early or late will induce a phase slip, as discussed
already in this thesis.
The particle radius and angular momentum were iterated in OPAL to find the stable
equilibrium orbit. Figures 6.8a, 6.9a, 6.10 and 6.11 details parameters from the initial
unoptimised particle radius and angular momentum. The initial starting radius was
identified from the stable equilibrium orbits for 1 MeV, 945mm, from Chapter 5, and
the initial angular momentum was set to 0βγ.
By iterating the starting phase, Equation 3.3 can be used to identify the starting
phases that reach the design energy which is known as the phase acceptance. A closer
94
6.3 HEATHER RF Studies
Figure 6.7: A depiction of a quadrant of stage 1, The injection angle is highlighted.
representation of phase acceptance can be attained by fitting an Equation to the ToF
curve for each stage to get a more accurate representation of the particle phase as a
function of energy. The improvement of the phase slip for stage 1 can be seen in Figure
6.10.
Post optimisation the orbit separation is much more uniform and the beam is well
centered around the machine as observed in Figures 6.8b, 6.9b, 6.10 and 6.11 . The
orbit separation observed is 2.5mm, which will be important when discussing extraction
later in this thesis. The phase acceptance for stage 1 and 2 are shown in Figure 6.12;
for the parameters used to find the optimal frequency.
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(a) Pre-optimisation
(b) optimised
Figure 6.8: The beam acceleration path before and after optimisation of the injection
parameters
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(a) Pre-optimisation
(b) optimised
Figure 6.9: The difference in mm between successive orbits before and after optimisation
of the injection parameters
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Figure 6.10: the phase of the particle relative to the RF phase before and after optimi-
sation
Figure 6.11: A comparison separation between orbits for a given point at 45◦ degrees
before and after optimisation
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(a) Stage 1
(b) Stage 2
Figure 6.12: HEATHER RF phase space plots showing the phase acceptance
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6.4 Realistic RF acceleration
For stage 1, a single gap cavity could be used, and single gaps were used to find the
optimal operating frequency. Delta type double gap resonators may be better suited
as they are typically used in first stage accelerators, such as in the RIKEN cyclotrons
discussed above. The delta type resonator configuration is depicted in Figure 6.13.
The idea of this thesis is to investigate the feasibility of this accelerator, so for stage 1
both a λ/2 delta type double gap resonator and a single gap resonator will be simulated.
The single gap cavities will be situated at 45◦ in the middle of a valley as shown in
Figure 6.5. In OPAL there is no configuration for delta type resonator, so two single
gap cavities were inserted 40 degrees apart. To achieve the 300 kVp, following the
Kilpatrick criterion, 4cm gaps will be used.
Using delta type double gap resonators, the energy gained per turn increases by a
factor of 2 because the number of accelerating gaps has doubled. Consequently, there is
an additional efficiency factor that is not considered in OPAL for delta type resonator
and two adjacent single gap cavities are used. This factor depends on the angle between
the cavities and harmonic used and is a further addition to Equation 6.1. Equation
6.10 gives the energy gained per turn using delta type double gap resonators





Where h is the harmonic and θ is equal to the angle between the cavities. The
sin(hθ2 ) term can be interpreted as an efficiency factor and this is shown Table 6.1
for varying harmonics. As discussed earlier in Section 6.3, the 5th harmonic is the
preferred option, but this still needs to be verified. Operating at 5th harmonic correlates
an efficiency factor of 0.98, which is a voltage loss of 24 keV per turn, which is negligible.






0.34 0.64 0.87 0.98 0.98 0.87 0.64 0.64
Table 6.1: Efficiency factor for varying harmonics for the delta type resonator angle of
40◦
Using OPAL, single gap and double gap cavities were simulated for both 200 and 300
kVp per accelerating gap. Lower voltages and single cap cavities are also simulated to
identify more probable alternatives if the desired RF design option cannot be achieved
when designed. A uniform voltage across the gap radially was used so the voltage gain
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Figure 6.13: The configuration of the delta type double gap λ/2 resonator simulated in
OPAL
per turn is the same for the purposes of this study. As delta type resonators are not
present in the OPAL code, the harmonics 1 and 2 for delta type resonator are ignored.
OPAL does account for the transit time factor, and this is done in all the simulations.
As discussed previously in 5.2.2, a 40◦ phase slip is the total phase slip tolerance
before beam quality begins to deteriorate. Figure 6.14 shows the total phase slip of a
single particle following the ideal acceleration equilibrium orbit for the different cavity
configurations.
The single gap cavities are not as effective as the double gap cavities and neither
single gap design can operate at 5th harmonic within the phase slip constraint. How-
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Figure 6.14: The configuration of the delta type double gap λ/2 resonator simulated in
OPAL
ever, it is identified that a single gap resonant cavity operating with an accelerating
voltage of 200 kVp would be the only option completely unsuitable for this design, as
the largest harmonic achievable within the phase slip constraint is the 2nd harmonic,
translating to an unrealistic cavity size of approximately 7.5m. A 300 kVp accelerating
voltage single gap resonator could be achievable and allow operation at 4th harmonic,
significantly reducing the cavity size to an achievable 3.75m. A cavity height of 3.57m
is large and slightly out of scope, but cavities of this magnitude have been constructed
before, and may be a compromise to be considered if the preferred designs are not
achievable from a full detailed RF design.
The desired double gap cavity design of 300 kVp fits within the design criteria,
and a cavity of similar design has already physically been constructed and will have
the RF parameters used for stage 1. If the preferred RF system is not achievable, the
more conservative delta type resonator design with a 200 kVp gap voltage is still an
acceptable alternative, with a compromise of a larger phase slip. Figure 6.15 shows the
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particle phase as a function of energy across the accelerating regime. Each line on the
graph shows a particle with a different starting phase, which was iterated from −90◦ to
90◦ in 5◦ increments. For all of the phase space plots the blue lines represent successful
acceleration to the design energy, the red lines show unsuccessful acceleration to the
design energy and the orange lines suggest the boundaries of starting phase likely to
reach the design energy. The range of starting phases that accelerate the particle to
the desired energy is known as the phase acceptance. The phase acceptance for these
designs have been investigated and found to be 85 and 70 degrees for 300 kVp and 200
kVp accelerating voltage respectively,
(a) 200 kVp gap voltage (b) 300 kVp gap voltage
Figure 6.15: HEATHER stage 1 RF phase space plots for delta type double gap resonators
with different accelerating gap voltages
6.5 Stage 2 RF
To keep the operating frequency of the cavities identical throughout the entire acceler-
ating regime, 5th harmonic will be used for stage 2. As discussed, single gap cavities
will be used, operating at 500 kVp per cavity gap. Two 8cm single gap cavities were
simulated in OPAL operating at 5th harmonic positioned as shown in Figure 6.16a.
Figure 6.16a shows the particle phase as a function of energy across the accelerating
regime. The phase acceptance for stage two was found to be ∼ 80◦ across the entire
acceleration regime, and the total phase slip approximately 36◦. To reduce the phase
slip, A higher accelerating voltage could be used across the cavity gap. An increased
accelerating gap voltage of 600 kVp was simulated to assess phase slip, which was found
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to be an improved 30◦, with a slightly increased phase acceptance of 90◦ as depicted in
6.16b.
(a) 500 kVp gap voltage (b) 600 kVp gap voltage
Figure 6.16: HEATHER stage 2 RF phase space plots for single type double gap res-
onators with different accelerating gap voltages
There is scope to us e an 8cm gap to increase the accelerating voltage beyond
600 kVp without reaching breakdown. However, the desire is to keep the design is
conservative, the 500 kVp design discussed here will be used to accelerate particles in
stage 2 from this point on in this thesis.
6.6 Chapter Summary
In this chapter an optimal fixed RF operating frequency has been established for the
entire accelerating regime across both stages of the accelerator design. A full detailed
RF design is beyond the scope of this thesis, but a realistic approach to selecting
parameters to simulate has been discussed and compared to current RF systems in
similar machines. The parameter selection addresses issues such as RF breakdown,
cavity height, operating harmonic number and accelerating gap size. The stage 1 RF
system has been chosen to be two half wavelength double gap delta type resonator,
with a gap voltage of 300 kVp, and stage 2 to be single gap RF cavities, with an





In the previous chapter the RF parameters for each stage of HEATHER were discussed,
the ideal particle was accelerated through both stages and different realistic cavity pa-
rameters were identified. Having identified optimal RF parameters and accelerating an
ideal particle through both stages, this chapter looks at accelerating a beam through
each stage of the accelerator with realistic emittances based on similar machines. Dif-
ferent emittances are optimised for acceleration through stage 1, and the changes in
emittance discussed. Extraction from stage 1 is discussed and the injection parameters
are optimised to maximise orbit separation. The extracted beam from stage 1 is then
injected into stage 2, and, as for stage 1, the emittance across the accelerating regime
is discussed. The injection parameters are then also optimised for stage 2 to identify
the maximum orbit separation achievable at extraction without making changes to the
magnetic field.
7.1 Pre-acceleration
The initial starting design energy for stage 1 will require pre-acceleration. The different
types of accelerators that could be used have all been described in 3.1. For HEATHER,
electrostatic acceleration is the most realistic option for pre-acceleration and the volt-
ages required to accelerate He2+ to 1 MeV are achievable and not technologically
limiting. Electrostatic acceleration is used to pre-accelerate at many established func-
tioning facilities, including many of those discussed in Chapter 6: RIKEN [123] [124],
PSI [112] [125], TRIUMF [126]. Other accelerators, such as a cyclotron, could be used
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to pre-accelerate and potentially allow higher energy injection where more space is
available, however the cost implications of this deem this inefficient. It is quite clear
that an electrostatic accelerator to reach 1 MeV is the most reasonable option, how-
ever its footprint may be large and may be an issue. The cost, footprint and type of
accelerator for pre-acceleration need to be investigated beyond this thesis.
7.2 Emittance
A beam can be described in 6 dimensions by its angle and position in each of the 3
orthogonal planes; x, y z. The size of a charge particle beam in phase space is typically
enclosed in an ellipse and called its emittance. Phase space describes an ensemble
of particles by their position and angle. The general expression for the emittance is




w = x, y, z (7.1)
Figure 7.1: Depiction of emittance, adapted from [127]
Where Aww′ is the area of the beam ellipse with beam width w, measured in mm
and beam angle w′ measured in mrad.
Without acceleration along a beam line the emittance remains invariant; its aspect
ratio or orientation may change but its value is constant. Because the emittance is
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invariant it can be related to the lattice, and using Equation 7.2 calculated using the
Twiss parameters; α, β and γ
ε = γw2 + 2αww′ + βw′2 w = x, y, z (7.2)
There are many different variations for the emittance, and in this thesis the RMS
emittance will be used, described by Equation 7.3, and depicted in Figure 7.1 RMS is
an abbreviation for root mean squared, and is a statistical way of achieving a magnitude
value of the average in a system that includes negative numbers
εwRMS =
√
〈w2〉 〈w′2〉 − 〈ww′〉2 w = x, y, z (7.3)
In accelerators normalised emittance may be used, which can be calculated using
equation 7.4. Under acceleration transverse momentum is conserved, but the longitudi-
nal momentum is increasing, reducing the angle in the longitudinal plane and reducing
the emittance. The reduction in emittance when accelerating a beam is called adiabatic
damping. During acceleration the normalised emittance is conserved.
εnormalised = βγεw (7.4)
7.3 Stage 1 Beam Acceleration
The beam emittance is constant in a non-accelerating system, but the emittance os-
cillates as the beam propagates around the machine. If the injected beam envelope
does not match that of the accelerator at injection, particle oscillations will occur and
cause emittance growth. The larger beam caused by emittance growth then makes the
beam more susceptible to resonances; hence reducing beam quality and complicating
extraction.
Without a full injection and pre-acceleration design, the exact beam emittance
that will be injected into the accelerator is unknown. Instead, the emittances used
are based on typical injected beams into similar particle accelerators, from standard
particle sources. These will give a good indication of what is possible and allow the
identification of what beam size it is possible to accelerate.
A range of 1, 2 and 5 πmmmrad emittances in all planes were injected into stage 1,
using a Gaussian distribution generated within OPAL to create the beam. As discussed
in Chapter 5, the co-ordinate system for OPAL, y is the longitudinal direction, x the
radial direction and z the vertical direction. The parameters necessary to generate a
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beam in OPAL are the RMS beam width and RMS angle.
Figure 7.2: The maximum emittance observed in each plane as a function of beam with
using the same initial injected emittance of 1 πmmmrad simulated in OPAL
To find the optimal injected emittance orientation, the emittance is kept constant
and the beam width and angles need to be changed. A range of beam widths were
iterated, and their corresponding angles are calculated for a fixed emittance. All planes
were iterated simultaneously as demonstrated by Figure 7.2 showing the maximum
emittance across the acceleration regime as a function of beam width of the injected
beam. Figure 7.3 shows the emittance profile in which the least growth was observed
in each plane from an initial injected beam with an emittance of 1 πmmmrad.
The initial radius and angular momentum values used were the same for the single
particle RF studies and will need to be corrected for a beam. Incorrect centering is
just as detrimental to a mismatched beam and can lead to unwanted emittance growth
and hence reduced beam quality. The radius and angular momentum of the beam was
optimised as described in previous chapters. The entire process was repeated again
for 2 and 5 πmmmrad and Figures 7.4a to 7.4c show the final optimised emittances
for all 3 initial emittances. It can be seen that there is some growth in the horizontal
and longitudinal planes peaking at around 65 MeV. Some growth was anticipated as
this is the closest working point on the tune map to the 2nd order resonance line
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Figure 7.3: The optimised emittance as a function of energy for each plane from an initial
injected emittance of 1 πmmmrad in each plane simulated in OPAL
(Figure 5.10). There appears to be no growth caused by the integer resonance crossing
approximately around 5 MeV as seen on Figure 7.3. The integer resonance crossing is
passed quickly over one turn and does not have enough time to effect the beam. The
growth that does occur is present for many turns, effecting the beam and visually seen.
As the injected emittance increases, the same relative emittance growth is observed,
except longitudinally, where the emittance growth is much larger for 5 πmmmrad. This
suggests that at a largest beam size the beam is much closer to the 2nd order resonance
line.
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(a) Optimised E(x) for injected emittances 1,2 and 5 πmmmrad simulated in
OPAL
(b) Optimised E(y) for injected emittances 1,2 and 5 πmmmrad simulated in
OPAL
(c) Optimised E(z) for injected emittances 1,2 and 5 πmmmrad simulated in
OPAL




Once accelerated to the desired energy the beam needs to be extracted and removed
from the accelerator. In one method for doing this the beam of particles passes in
between a thin metallic plate, known as a septum, and an electrode. Creating an
electric field between the septum and the electrode, the particles receive a kick and
are steered off orbit and directed in between the electrode and septum where they are
extracted from the machine, as shown in Figure 7.5 [128].
Figure 7.5: A depiction of cyclotron extraction by use of a septum, taken from [128]
As the energy of the particles increases, the radial separation between successive
orbits reduces, which can be identified from Equation 3.9. Eventually in any cyclotron
the orbits will begin to overlap, and multi-turn extraction may occur, changing the
energy spread of the beam and causing losses on the septum. Losses on the septum can
lead to further unwanted issues such as activation; creating unwanted secondaries. Ac-
tivation and unwanted secondaries have the potential to increase the amount shielding
required, but more importantly, the potential to harm from highly ionising radiation
if maintenance is essential for function. Turn separation needs to be maximised to in-
crease the probability that only the desired orbit is extracted. The necessary size needs
to be enough to accommodate a septum for electrostatic extraction. Initial septum
thicknesses have been found to be between 50µm and 250µm. It is important to note
the septum thicknesses quoted are for the thicknesses at the start of the septum as they
typically increase in size radially, where the thickness can increase into several mm. To
be conservative, the minimum orbit separation necessary should be 0.5mm. [129] [130]
[131] [132] [133].
In cyclotrons the easiest way to increase turn separation is to increase the energy
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gain per turn which can be done in either 2 ways; increasing the RF voltage or by
increasing the number of cavities. For higher energy machines, the RF design may
already be at the boundary of what is possible, and different ways of increasing orbit
separation may be necessary by altering the magnetic field at the extraction radius
[134].
Resonant extraction utilises betatron oscillations to separate successive orbits and
can be done via brute force or processionally. Brute force is the addition of coils to the
magnets to create field bumps and pushes the beam onto a resonance. Processional
resonant extraction is where the beam crosses a resonance and the betatron oscillations
gradually increase around the equilibrium orbit and increase turn separation. As a
result it crosses the resonance, changing the working point, affecting the particles path
length and hence its frequency. The change in frequency between the two orbits crossing
the resonance will induce a phase slip and additionally increase the turn separation
[134].
Another method of extraction which is unsuitable for He2+, but is still mentioned
for completion, is stripping extraction. In this extraction method the beam is a negative
ion and when the desired energy is reached the beam passes through a stripping foil,
usually made of carbon, and the ions are stripped of electrons. This reverses the charge
on the ion, and opportunely the magnets force on the particle is now reversed. Where
the negative ion was processing around the machine the particle is steered away by
cyclotron magnets, and down a beam line to be extracted [134].
7.5 Stage 1 Extraction
After optimising the beam and reducing the emittance growth by matching, the beam
orbit separation at extraction needs to be investigated. To assess the orbit separation
at extraction in more detail, the last 5 orbits were investigated at the middle of a valley,
where the beam would be extracted. To assess the last 5 orbits, a radial probe was
inserted at 45◦ and the particles radial position when crossing is recorded. The radial
positions of the particle were then binned, using a bin size of 0.2mm. Current optimi-
sation of the stable acceleration orbit focuses on as close to equidistant orbit separation
as possible, as described and demonstrated in Chapter 5. By not achieving equidistant
orbit separation, the orbit separation distance oscillates throughout acceleration, and
on sequential orbits the bunches get closer or further away. This is known as orbit
bunching. Orbit bunching could be used to increase the orbit separation at extrac-
tion. Bunching orbits closer together may allow latter orbits to spread out, achieved
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by changing the injected beam radius and angular momentum.
The ideal acceleration orbit identified in Figure 7.6b shows peak to peak orbit
separation at extraction for stage 1 to be ∼ 2.5mm. For a beam this distance is
expected to reduce, with increasing beam size, and there is the potential to overlap.
The injection parameters found for the ideal orbit separation for a single particle were
used when injecting a beam for three different studied emittances, 1, 2 and 5 πmmmrad,
shown in Figure 7.6a. For the ideal particle the orbit separation in mm was peak to
peak, however for the injected beams the orbit separation shown is between the largest
radial particle and the closest radial particle between successive turns. The injection
parameters were then optimised to better suit the separation between orbits for beams
as opposed to a single particle, as shown in Figure 7.6b.
(a) before optimisation (b) Post optimisation
Figure 7.6: Radial successive orbit separation per turn for different injected beam sizes
From Figure 7.6 It can be seen that after optimising the injection parameters for
the studied emittances, the orbit separation is much improved for all injected beam
sizes. For the 1 and 2 πmmmrad cases, there is no particle overlap throughout the
entire acceleration regime, however overlap is observed after the first 100 turns for
the injected 5 πmmmrad. Looking in detail at the extraction orbits, the peak to
peak distance and the 2σ distances between successive orbits were identified. As the
distribution is Gaussian, there will typically be a tail of particles which extend beyond
the majority of the particles. The 2σ boundaries will identify regions where 95% of the
particles will be confined. The extraction orbit was identified as the first orbit with a
peak energy greater than 400 MeV.
From Figure 7.7 it can be seen that all peak to peak distances are more than 3mm
apart, and the extraction peak to peak distances are 3.95 and 5.71mm for 1πmmmrad
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(a) 1πmmmrad (b) 2πmmmrad
Figure 7.7: The radial profile of a He2+ beam for the last 5 turns for different initial
beam sizes
and 2πmmmrad beams, respectively. Assessing the distances between the 2σ boundaries
of successive peaks shows distances of greater than 2.5mm between each peak except
for between the 3rd and 4th peak for the 2πmmmrad injected beam, where the distance
is reduced to 1.12mm to allow for larger separation for the extraction orbit. Although
not highlighted, there is a clear separation with no overlap of at least 1mm between
all orbits for both cases, bar the 3rd and 4th peak for the 2nd case where there is tail
overlap. Figure 7.8, the largest injected beam size of 5πmmmrad has similar peak to
peak distances compared to the smaller beam sizes but the wider beam reduces the
2 σ distances, with an overlap between the 3rd and 4th peak, and there is no clear
separation between orbits.
As identified earlier, a gap of 0.5mm should be sufficient to insert a septum in
between successive orbits. A gap of 0.5mm and is more than achievable for 1 and 2
πmmmrad injected beams and no particles should directly hit the septum. This is not
the case for the 5πmmmrad injected beam. The simulations suggest there is enough
space between the 2σ boundaries of the peaks for a septum, however the tails of the
Gaussian distribution will likely be lost as they will hit the septum. Based on these
results, the extracted 2πmmmrad beam will be accelerated through stage 2.
7.6 Stage 2 Beam Acceleration
From Stage 1 the RMS beam width and emittance were taken exactly from the beam
distribution at extraction from the initial injected 2πmmmrad and were used identically
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Figure 7.8: The radial profile of a He2+ beam for the last 5 turns for an He2+ beam with
an initial emittance of 5πmmmrad
to insert a beam into stage 2. Initial optimisation changed the injection radius and
angular momentum to produce equidistant orbits as shown in Figure 7.10 and then
re-optimised to maximise the extraction orbit separation as depicted in Figure 7.11.
The emittances in each plane are depicted in Figure 7.9 where no matching, as done
for stage 1, was completed as there was no unusual growth from resonances.
Looking at the two optimised states of the last 5 orbits, it is clear from both cases
that overlapping will occur, and losses will occur from hitting the septum. The peak to
peak distance for the equidistant optimisation is approximately 2mm, however this has
more than doubled to 4.13mm when bunching orbits radially. There is no 2σ boundary
separation for the equidistant case however a separation of 1.75mm for the extraction
orbit is present with bunching suggesting that it is possible to fit a septum in between
the orbits, and it is estimated that losses on the septum will be a maximum of 4.2%. It
is not foreseen that the bunched orbits will be an issue as they will be radially before
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Figure 7.9: Stage 2 emittance growth across the acceleration regime
the inserted septum and will not affect the energy spread of the extracted beam. An
example where orbits are bunched pre-extraction is the PSI ring cyclotron [116].
In practice, if the losses look like they will be a problem, there is potential to increase
the gap size by using resonant extraction. From the working point diagram, it may
be possible to achieve either brute force or processional extraction, as it appears to be
heading towards an integer resonance. Larger orbit separation may also be achievable
by reducing the emittance size, but it still unlikely that there will be no overlap and
no losses on the septum.
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Figure 7.10: The radial profile of a He2+ beam from stage 1 with initial emittance of
2πmmmrad optimised to make the peaks equidistant
Figure 7.11: The radial profile of a He2+ beam from stage 1 with initial emittance of
2πmmmrad optimised to maximise the extraction peak separation orbit
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7.7 Magnetic Field Error
Magnets are never manufactured perfectly or identical to the design specification, and
it is likely that there will be some discrepancy from the provided field map to what is
achievable. Beyond this when manufactured and in place environmental factors such as
temperature and local ferrous material can distort the magnetic field. To consider the
potential effects of an imperfect field gradient two methods of magnetic error analysis
are explored; the addition of up to ±1% of error on the magnetic fields and the addition
or subtraction of up to a fixed value of error. Note that these errors are larger than
normally achieved in magnet manufacture. Field Errors have only been introduced
where a magnetic field is present, so there are no errors in the valley sections. Based
on the previous optimisation work from it is expected that the introduced field map
errors will have a larger effect on the isochronicity profile than the working point and
disrupt the stable acceleration orbit.
7.7.1 Stage ± 1% error field map
Initially ±1% of the field was added to the field map for stage 1, by randomly assigning
values to the field map before being read by OPAL and investigated. This initial concept
was adventurous as the error will increase with the field gradient and more than likely
exceed the size of the error. The errors were introduced and the isochronicity compared
to the original field map in Figure 7.12a. It was not possible to calculate the tunes
for the adjusted map. It became increasingly difficult to find stable orbits, as depicted
by Figure 7.12b, which was due to the growth of the error. It can be seen the outer
orbits have greater oscillations and a stable orbit could not be confined further.
It is thought that the radial field error made it difficult to find a stable acceleration
orbit, however it was possible to accelerate a particle to the design energy. Unfortu-
nately the design is very fragile, and when varying the initial phase of the particle to
find the phase acceptance, the particle no longer reaches the design energy and is lost,
as shown in Figure 7.13.
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(a) Isochronicity variation with error
(b) 2πmmmrad
Figure 7.12: Stable orbit properties introducing 1% error on the magnetic field
Figure 7.13: The RF phase space with an introduced percentage error. The accelerated
is unstable, and the design energy is not reached when changing the initial phase of the
particle
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7.7.2 Stage 1 fixed error field map
This method of analysis used a fixed value of error along each point of the magnetic
field, which is probably a more representative way of calculating the magnetic field error.
Two fixed error values were used, 1% and 0.5% of the the lowest azimuthal magnetic
field value; 3 Tesla. The stable orbits and isochronicity profile were not calculated for
these field maps, as for the above error analysis the isochronicity seems reasonable,
however acceleration was unsuccessful. Optimisation for the fixed error looked at the
phase acceptance and compared it to the % error phase acceptance. Figures 7.14a and
7.14b show the phase space for 1% and 0.5% respectively. It can be seen that the phase
acceptance with varying percentage in Figure 7.13 is comparable to the higher fixed
error case, displayed by Figure 7.14a, suggesting that the size of the error is the cause of
the instability. The reduced fixed error limit was found to be more acceptable, and a 30◦
phase acceptance was identified, advocating that this sort of error could be tolerated.
This method used for studying errors is indicative, but a more apt method may be to
go back to FACT and introduce errors for each magnetic order before generating the
field map for OPAL, as opposed to adding it randomly afterwards.
(a) 1% B0 fixed error (b) 0.5% B0 fixed error





With the current increasing popularity of particle therapy, the growth of proton ther-
apy demonstrates the clinical interest globally in using particles for therapy. There
are physical and clinical benefits when using ions heavier than protons, however the
cost and size of these facilities make it very difficult to justify and implement. The
limited availability also restricts research and the clinical rationale takes longer to gen-
erate. Beyond this, these machines that can accelerate ions are complex, and typically
require specialist expertise to operate. A cheaper simpler compact alternative could
increase the availability of ion therapy and enable further research in to heavier ions
for radiotherapy.
A two stage non-scaling Fixed Field Alternating Gradient (nsFFAG) accelerator
for the purpose of accelerating He2+ ions for particle therapy has been successfully
designed. A nsFFAG design was chosen to provide a compact solution to provide fast
CW acceleration of ions. The final achievable energy of 900 MeV clinically translates
to approximately 30cm depth, and is necessary treat deep seated tumours.
The design was split into two stages, identified as stage 1 and stage 2. Stage 1
accelerates He2+ ions from 1 MeV to 400 MeV using a four sector magnet design. The
field strength of the magnets causes overlapping of the fringe field at the inner radii
which suppresses the vertical tune and decreases the path length. Once the orbits pass
the fringe field overlap the isochronicity is within tolerances and the tune recovers.
An integer resonance is crossed during acceleration, the crossing is fast and nearly
perpendicular, so beam growth is minimised. Delta type double gap λ⁄2 cavities with
an accelerating voltage of 300kV per gap were found to be optimal for the design,
operating at 50.46MHz.
Stage 2 is a racetrack design consisting of 6 sectors, accelerating from 400 MeV to
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900 MeV. The racetrack design prevents any fringe field overlap, and provides more
room for cavities, injection and extraction. The isochronicity for this stage was matched
to within 1% of stage 1, enabling acceleration of the same frequency for both stages.
The working point for this machine avoids integer resonance crossings but crosses a
2nd order resonance initially. Single gap resonant cavities were found to be optimal for
this design, with an accelerating voltage of 500kV, operating at 50.46MHz.
Different beam sizes were accelerated that are typically representative of current ac-
celerators, and a beam of 2πmmmrad has been shown to be capable of being accelerated
through both stages. The beam was matched into stage 1, and directly inserted into
stage 2, and was accelerated through the accelerator without the need for matching.
The initial accelerating beam parameters were optimised, and a clear 1mm between
the last two orbits was identified; no losses are expected from the beam hitting the
septum placed between the orbits when extracting. The initial beam parameters for
stage 2 were optimised to maximise orbit separation for extraction. It was found that
by overlapping the successive orbits before extraction, a larger separation between the
last two orbits can be achieved. In this case there is some overlap, and minimal losses
are expected on the septum. This work has demonstrated the potential of a nsFFAG
for helium ion therapy.
8.1 Future work
There are still aspects of this design that need to be further explored which are beyond
the scope of this thesis.
8.1.1 Particle source and pre acceleration
Pre acceleration was discussed in Chapter 7, but the particle source has not been con-
sidered. Although the beam emittance used was estimated using existing ion sources,
the source and pre accelerator will determine the size of the beam entering stage 1. It
looks likely the emittance will be smaller than anticipated, which will improve orbit
separation for extraction.
8.1.2 Transfer lines
Two beam lines will need to be designed; from the pre-accelerator into stage 1, and
stage 1 into stage 2. This will require a full detailed study, and software such as MADX
[135] can be used to model the beam lines. From the simulations in Chapter 7 the
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beam line design between stage 1 and stage 2 should require no matching and be a
simple drift tube. The first beam line may require more work.
8.1.3 Magnet design
Although work has been completed on the magnet design, a full 3D model of the
magnets needs to be completed. This will confirm the azimuthal gradient, the size
of the pole gap, the magnet dimensions and error tolerances. This work will need to
be completed in specialist software like Opera3D [136]. Detailed Magnet studies have
already started for the other nsFFAG design in our group, PIP, [108] using Opera3D,
as shown in Figure 8.1
Figure 8.1: Magnet design work for PIP, a different FFAG design within the collaboration
[108] [137].
8.1.4 RF design
The RF system also requires a full detailed cavity design. Realistic properties were
considered in this thesis, increasing the likelihood that the desired outcome will be
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feasible, but ultimately this is unknown until the cavities are specifically designed. It
is expected that a cavity design will be studied in finite element analysis software, e.g.
computer simulation technology (CST) [138].
8.1.5 Variable Energy
Currently the design extracts at single energy, but there is an idea within the group to
use harmonic jumping for variable energy extraction. If variable energy is not achievable
the extracted beam will need to be degraded. The consequence of beam degradation
for particles are the low secondaries produced, and the increased shielding necessary
because of it. This could be investigated using Monte Carlo simulations to both degrade
the beam, and calculate the shielding necessary. I have already completed work using
MCNPX [139] for a similar project in collaboration with the Front End Test Stand
(FETS) the Rutherford Appleton laboratory (RAL), UK [140]. The 3 MeV proton
beam leaving the accelerator will be disposed of by depositing the beam into a beam
dump, an aluminium conical shape surrounded by water. I used MCNPX to simulate
a proton beam hitting the beam dump, and assessed the interactions between protons
and aluminium, and looked to see if shielding being used would be sufficient (Figure
8.2). A full shielding design will go beyond this, taking into consideration annual dose
restrictions for surrounding rooms and typical workloads of the machine. There is
scope to complete this work with a Radiation Protection Advisor (RPA) and treat
the shielding design as if it was going into a current hospital, following the relevant
legislation [141] and guidelines [142].
(a) The FETS beam dump geometry
built in MCNPX. The figure shows is a
slice in the YZ plane. Blue represents the
beam dump.
(b) After inserting concrete shielding the
photons penetrating the concrete are re-
duced by a factor of 103





Further detailed work needs to be carried out on the extraction on both stages. The
use of the brute force method by introducing field bumps would be the easiest way to
investigate this. It may be necessary to look at other codes to study this further.
8.1.7 Beyond the current design
There is also scope to modify the designs of the accelerators, and further alter the field
maps. It could be possible to alter the field map to reach 900 MeV with one stage as
opposed to two stages. This would reduce the footprint and make the project much
cheaper. Both stages can exceed their design energy, with a phase slip, by up to 40%.
This needs to be further investigated as the current design does not reach the necessary
energy to image with ionised dihydrogen, but it is clear there is a possibility to do this.
The RF for stage 2 could be redesigned to use 4 cavities in corner spaces, which could
increase orbit separation.
8.2 Summary
In this thesis, the question as to whether it is feasible to accelerate He2+ to 900 MeV in a
compact accelerator that could fit in current medical facilities, has been investigated and
I believe it has been answered. The accelerator that has been designed, HEATHER, has
demonstrated that a nsFFAG solution could be compact enough to fit in the basement
of a hospital. Technological and physical boundaries have been considered, and a
conservative approach taken as to not push these limitations. Manufacturing aspects
have been considered, where all of the magnet parameters are identical, simplifying the
process. Clinically the machine should be easy to use, like other medical isochronous
cyclotrons, where minimal specialised staff are required to run the facility. The design
itself is also split across two stages, where the first stage extracts a beam with energy
of 100 MeV/u. Clinically stage one could be used without stage 2 for research purposes







below is an example input for FACT in the Enge Edge format.
NSFFAG 2 2 (this dictates the amount of magnets)
P12 1 (first line)
0.04727592878 0.01627840772 (start z, length)
1.56010565 0.5371874549 (start x, length)
P21 1 (second line)
0.01627840772 0.04727592878 (start x, length)
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